≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Bronchus and lung

DOID EFO Endpoint Browser PheWeb

CD2_BENIGN_BRONCHUS_LUNG

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D14.3&
  • Hospital discharge: ICD-9 — 2123
  • Hospital discharge: ICD-8 — 2123
  • Cause of death: ICD-10 — D14.3&
  • Cause of death: ICD-9 — 2123
  • Cause of death: ICD-8 — 2123

2 out of 7 registries used, show all original rules.

493

4. Check minimum number of events

None

493

5. Include endpoints

None

493

6. Filter based on genotype QC (FinnGen only)

484

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D14
Name in latin
Neoplasma benignum bronchi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3012 1351 1630
Only index persons 2312 1123 1189
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.05
Only index persons 0.04 0.04 0.05
Median age at first event (years)
Whole population 57.62 56.60 58.38
Only index persons 56.62 55.59 57.59

-FinnGen-

Key figures

All Female Male
Number of individuals 484 213 271
Unadjusted period prevalence (%) 0.10 0.08 0.12
Median age at first event (years) 58.68 55.43 61.24

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
493
Matched controls
4930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
+∞
307.7
387
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
38.4
275.0
185
76
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
20.1
263.9
293
335
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
118.7
83.1
88
9
2123A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Bronchus and lung
+∞
82.7
77
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.7
82.6
140
242
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
265.2
47.9
48
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
12.9
46.1
46
39
GDA20
NOMESCO Finland
Excision of lesion of lung
478.9
45.0
44
*
21230
ICD-8 Finland
Benign neoplasm of respiratory system, Bronchus and lung
+∞
35.9
34
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
33.8
155
572
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
82.6
28.1
31
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
10.3
27.9
32
33
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.1
27.2
61
132
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.1
26.8
42
64
GD1AD
NOMESCO Finland
Thorax CT examination
4.4
26.4
72
183
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
25.4
65
157
5823
FHL
Lung avobiopsy and wedge resection
87.7
22.9
25
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.6
20.5
52
124
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
19.6
296
1899
WX402
NOMESCO Finland
General anaesthesia
2.4
16.3
139
684
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
27.3
15.7
21
8
5822
FHL
Exploratory thoracotomy and small procedure (eg lung suture)
165.0
15.6
16
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
15.0
86
347
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.6
13.5
85
360
N02AX02
ATC
tramadol; systemic, rectal
2.0
13.0
251
1675
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
+∞
12.6
12
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
12.4
76
317
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
9.6
12.1
24
26
GDB10
NOMESCO Finland
Wedge resection of lung
+∞
11.5
11
*
GDC00
NOMESCO Finland
Lobectomy of lung
20.6
11.2
16
8
R05
ICD-10 Finland
Cough
2.1
11.2
122
655
1240
FHL
Bronchoscopy
8.9
11.1
23
27
5188X
ICD-9 Finland
Other diseases of lung
61.4
10.7
12
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
8.5
10.4
22
27
WX250
NOMESCO Finland
Intercostal blockade
24.0
10.3
14
6
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
24.0
10.3
14
6
R03BB04
ATC
tiotropium bromide; inhalant
2.4
10.1
75
342
GDA10
NOMESCO Finland
Biopsy of lung
41.0
10.0
12
*
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
20.5
9.8
14
7
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.9
9.8
49
183
R4110
NOMESCO Finland
Physiotherapy
1.9
9.2
154
954
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.8
9.0
45
168
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.6
158
1004
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
28.1
8.5
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
8.4
138
846
23130
ICD-8 Finland
Neoplasm of unspecified nature of respiratory organs, Bronchus and lung
+∞
8.4
8
*
1243
FHL
Bronchoscopy and other therapeutic procedure
+∞
8.4
8
*
ZXE00
NOMESCO Finland
One hour or less
1.8
8.3
194
1322
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
14.8
8.2
13
9
5826
FHL
Lobectomy or bilobectomy
33.9
8.1
10
*
XG410
NOMESCO Finland
Flow-volume spirometry
3.2
8.0
31
100
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.9
7.8
36
129
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.9
7.6
37
136
B01AB05
ATC
enoxaparin; parenteral
1.8
7.6
168
1123
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
30.5
7.2
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
7.1
181
1255
B01AB04
ATC
dalteparin; parenteral
2.9
6.8
31
110
R04.2
ICD-10 Finland
Haemoptysis
3.2
6.7
27
89
XG405
NOMESCO Finland
Education on PEF monitoring
6.6
6.7
16
25
N03AX16
ATC
[U] pregabalin
1.8
6.6
122
769
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
70.7
6.4
7
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
6.4
186
1326
D14.4
ICD-10 Finland
Benign neoplasm: Respiratory system, unspecified
+∞
6.3
6
*

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Pulmonary Disease
29 [38004472]
4.0e-01
3.6e+00
4.0e+00
—
3.3e+00
2.5e+00
1.3e+00
cases:12.50%
controls:8.74%
cases:61.85%
controls:4.35%
cases:33.41%
controls:0.93%
—
—
cases:15.33%
controls:0.65%
cases:36.67%
controls:4.73%
cases:29.83%
controls:10.08%
58
404
406
4219
287
201
177
4422
155
43
309
4580
—
71
30
392
4590
165
215
285
4334
122
418
287
3728
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
2.0e+00
5.2e+00
—
1.0e+50
—
3.5e+00
1.5e+00
cases:6.68%
controls:0.93%
cases:41.38%
controls:0.39%
—
—
cases:5.60%
controls:0.00%
—
—
cases:8.44%
controls:0.29%
cases:4.40%
controls:1.01%
31
43
433
4580
192
18
272
4605
—
26
0
438
4623
—
38
13
412
4536
18
42
391
4104
Thorax X-ray examination
GD1AA [2001303617]
6.5e-02
2.0e+00
3.2e+00
1.0e+50
2.8e+00
2.0e+00
9.8e-01
cases:7.33%
controls:6.90%
cases:18.10%
controls:2.77%
cases:6.25%
controls:0.28%
cases:9.27%
controls:0.00%
cases:4.10%
controls:0.26%
cases:14.67%
controls:2.29%
cases:19.80%
controls:8.51%
34
319
430
4304
84
128
380
4495
29
13
435
4610
43
0
421
4623
19
12
444
4608
66
104
384
4445
81
353
328
3793
Outpatient Visit
OP [9202]
1.4e-01
1.1e+00
1.8e+00
4.8e+00
1.5e+00
9.7e-01
3.6e-01
cases:64.66%
controls:61.35%
cases:69.61%
controls:42.29%
cases:37.07%
controls:9.00%
cases:38.15%
controls:0.50%
cases:30.67%
controls:8.64%
cases:67.11%
controls:43.59%
cases:76.77%
controls:69.71%
300
2836
164
1787
323
1955
141
2668
172
416
292
4207
177
23
287
4600
142
399
321
4221
302
1983
148
2566
314
2890
95
1256
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
8.1e-01
1.9e+00
2.9e+00
—
2.3e+00
1.8e+00
1.3e+00
cases:3.45%
controls:1.56%
cases:5.39%
controls:0.87%
cases:3.02%
controls:0.17%
—
—
cases:1.73%
controls:0.17%
cases:5.56%
controls:0.95%
cases:7.33%
controls:2.15%
16
72
448
4551
25
40
439
4583
14
8
450
4615
—
8
8
455
4612
25
43
425
4506
30
89
379
4057
Physiotherapy
R4110 [2001310233]
1.8e-01
2.2e+00
3.3e+00
—
2.0e+00
1.4e+00
1.1e+00
cases:4.74%
controls:3.98%
cases:9.91%
controls:1.25%
cases:3.45%
controls:0.13%
—
—
cases:1.30%
controls:0.17%
cases:4.22%
controls:1.08%
cases:9.05%
controls:3.18%
22
184
442
4439
46
58
418
4565
16
6
448
4617
—
6
8
457
4612
19
49
431
4500
37
132
372
4014
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
—
3.9e+00
—
—
—
4.2e+00
1.2e+00
—
—
cases:16.38%
controls:0.41%
—
—
—
—
—
—
cases:15.56%
controls:0.26%
cases:3.42%
controls:1.09%
—
76
19
388
4604
—
—
—
70
12
380
4537
14
45
395
4101
Inpatient Visit
IP [9201]
3.2e-02
1.8e+00
3.2e+00
—
3.0e+00
1.2e+00
3.8e-01
cases:9.48%
controls:9.21%
cases:18.10%
controls:3.63%
cases:6.47%
controls:0.28%
—
—
cases:6.91%
controls:0.37%
cases:10.22%
controls:3.45%
cases:13.45%
controls:9.60%
44
426
420
4197
84
168
380
4455
30
13
434
4610
—
32
17
431
4603
46
157
404
4392
55
398
354
3748
enoxaparin; parenteral
B01AB05 [21600976]
1.8e-01
1.2e+00
2.6e+00
—
3.6e+00
1.3e+00
5.9e-01
cases:5.39%
controls:4.54%
cases:3.88%
controls:1.17%
cases:1.94%
controls:0.15%
—
—
cases:6.70%
controls:0.19%
cases:4.22%
controls:1.17%
cases:7.09%
controls:4.05%
25
210
439
4413
18
54
446
4569
9
7
455
4616
—
31
9
432
4611
19
53
431
4496
29
168
380
3978
Flexible bronchoscopy
UGC12 [2001303610]
8.9e-01
4.4e+00
1.0e+50
1.0e+50
—
2.6e+00
1.5e+00
cases:1.51%
controls:0.63%
cases:13.79%
controls:0.19%
cases:4.74%
controls:0.00%
cases:1.72%
controls:0.00%
—
—
cases:3.11%
controls:0.24%
cases:3.18%
controls:0.72%
7
29
457
4594
64
9
400
4614
22
0
442
4623
8
0
456
4623
—
14
11
436
4538
13
30
396
4116
FEV1/FVC --post bronchodilation
69970-2 [42868459]
9.7e-01
3.4e+00
—
—
—
2.0e+00
1.8e+00
cases:3.66%
controls:1.43%
cases:11.21%
controls:0.43%
—
—
—
—
—
—
cases:3.56%
controls:0.48%
cases:4.40%
controls:0.77%
17
66
447
4557
52
20
412
4603
—
—
—
16
22
434
4527
18
32
391
4114
FEV1 percent change
69983-5 [42868472]
9.7e-01
3.4e+00
—
—
—
2.0e+00
1.8e+00
cases:3.66%
controls:1.43%
cases:11.21%
controls:0.43%
—
—
—
—
—
—
cases:3.56%
controls:0.48%
cases:4.40%
controls:0.77%
17
66
447
4557
52
20
412
4603
—
—
—
16
22
434
4527
18
32
391
4114
FEV1 --post bronchodilation
20155-8 [3023550]
9.7e-01
3.4e+00
—
—
—
2.0e+00
1.8e+00
cases:3.66%
controls:1.43%
cases:11.21%
controls:0.43%
—
—
—
—
—
—
cases:3.56%
controls:0.48%
cases:4.40%
controls:0.77%
17
66
447
4557
52
20
412
4603
—
—
—
16
22
434
4527
18
32
391
4114
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
9.7e-01
3.4e+00
—
—
—
2.0e+00
1.8e+00
cases:3.66%
controls:1.43%
cases:11.21%
controls:0.43%
—
—
—
—
—
—
cases:3.56%
controls:0.48%
cases:4.40%
controls:0.77%
17
66
447
4557
52
20
412
4603
—
—
—
16
22
434
4527
18
32
391
4114
FVC percent change Respiratory system
69982-7 [42868471]
9.7e-01
3.4e+00
—
—
—
2.0e+00
1.8e+00
cases:3.66%
controls:1.43%
cases:11.21%
controls:0.43%
—
—
—
—
—
—
cases:3.56%
controls:0.48%
cases:4.40%
controls:0.77%
17
66
447
4557
52
20
412
4603
—
—
—
16
22
434
4527
18
32
391
4114
FEV1/FVC
19926-5 [3011505]
9.8e-01
3.1e+00
—
—
—
2.0e+00
2.0e+00
cases:4.09%
controls:1.58%
cases:11.64%
controls:0.56%
—
—
—
—
—
—
cases:4.00%
controls:0.57%
cases:5.87%
controls:0.87%
19
73
445
4550
54
26
410
4597
—
—
—
18
26
432
4523
24
36
385
4110
FEV1
20150-9 [3024653]
9.8e-01
3.1e+00
—
—
—
2.0e+00
2.0e+00
cases:4.09%
controls:1.58%
cases:11.64%
controls:0.56%
—
—
—
—
—
—
cases:4.00%
controls:0.57%
cases:5.87%
controls:0.87%
19
73
445
4550
54
26
410
4597
—
—
—
18
26
432
4523
24
36
385
4110
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
9.8e-01
3.1e+00
—
—
—
2.0e+00
2.0e+00
cases:4.09%
controls:1.58%
cases:11.64%
controls:0.56%
—
—
—
—
—
—
cases:4.00%
controls:0.57%
cases:5.87%
controls:0.87%
19
73
445
4550
54
26
410
4597
—
—
—
18
26
432
4523
24
36
385
4110
Thorax extensive CT-examination
GD1BD [2001303621]
—
3.6e+00
—
1.0e+50
—
2.3e+00
2.0e+00
—
—
cases:4.74%
controls:0.13%
—
—
cases:1.29%
controls:0.00%
—
—
cases:1.11%
controls:0.11%
cases:2.20%
controls:0.29%
—
22
6
442
4617
—
6
0
458
4623
—
5
5
445
4544
9
12
400
4134
Oncology Clinic/Center
261QX0200X [38004268]
5.3e-04
1.3e+00
3.2e+00
—
2.1e+00
1.5e+00
5.9e-01
cases:5.17%
controls:5.17%
cases:4.96%
controls:1.47%
cases:2.59%
controls:0.11%
—
—
cases:2.16%
controls:0.28%
cases:4.22%
controls:0.99%
cases:8.31%
controls:4.78%
24
239
440
4384
23
68
441
4555
12
5
452
4618
—
10
13
453
4607
19
45
431
4504
34
198
375
3948
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
7.3e-02
9.4e-01
2.1e+00
2.4e+00
1.8e+00
5.6e-01
3.0e-01
cases:24.35%
controls:23.04%
cases:32.76%
controls:16.03%
cases:20.47%
controls:3.01%
cases:2.16%
controls:0.19%
cases:13.39%
controls:2.58%
cases:24.44%
controls:15.54%
cases:39.36%
controls:32.54%
113
1065
351
3558
152
741
312
3882
95
139
369
4484
10
9
454
4614
62
119
401
4501
110
707
340
3842
161
1349
248
2797
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-1.7e-03
6.9e-01
2.1e+00
2.6e+00
1.6e+00
4.3e-01
3.4e-01
cases:18.75%
controls:18.78%
cases:27.80%
controls:16.14%
cases:21.34%
controls:3.20%
cases:2.37%
controls:0.17%
cases:13.82%
controls:3.18%
cases:22.67%
controls:16.03%
cases:37.90%
controls:30.34%
87
868
377
3755
129
746
335
3877
99
148
365
4475
11
8
453
4615
64
147
399
4473
102
729
348
3820
155
1258
254
2888
Supplier / Service Provider
OMOP5117446 [33004]
-1.2e+00
5.4e-01
1.8e+00
—
—
3.0e+00
3.2e+00
cases:11.64%
controls:30.89%
cases:16.38%
controls:10.27%
cases:7.97%
controls:1.43%
—
—
—
—
cases:10.00%
controls:0.57%
cases:18.34%
controls:0.87%
54
1428
410
3195
76
475
388
4148
37
66
427
4557
—
—
45
26
405
4523
75
36
334
4110
Outpatient Hospital
22 [8756]
-8.3e-02
1.5e+00
2.4e+00
—
2.0e+00
8.6e-01
5.1e-01
cases:20.69%
controls:22.09%
cases:23.06%
controls:6.38%
cases:7.76%
controls:0.76%
—
—
cases:5.40%
controls:0.74%
cases:13.33%
controls:6.11%
cases:24.45%
controls:16.26%
96
1021
368
3602
107
295
357
4328
36
35
428
4588
—
25
34
438
4586
60
278
390
4271
100
674
309
3472
Tissue Pathology biopsy report
66121-5 [40768804]
9.0e-02
1.7e+00
2.7e+00
—
1.9e+00
9.7e-01
3.6e-01
cases:6.90%
controls:6.34%
cases:12.28%
controls:2.57%
cases:4.31%
controls:0.30%
—
—
cases:2.38%
controls:0.37%
cases:5.11%
controls:2.00%
cases:10.27%
controls:7.38%
32
293
432
4330
57
119
407
4504
20
14
444
4609
—
11
17
452
4603
23
91
427
4458
42
306
367
3840
Vascular Surgery
77 [38004496]
4.0e-02
1.0e+00
2.6e+00
1.0e+50
2.9e+00
1.6e+00
3.7e-01
cases:2.59%
controls:2.49%
cases:3.02%
controls:1.12%
cases:1.94%
controls:0.15%
cases:4.31%
controls:0.00%
cases:2.81%
controls:0.15%
cases:4.89%
controls:1.08%
cases:4.16%
controls:2.92%
12
115
452
4508
14
52
450
4571
9
7
455
4616
20
0
444
4623
13
7
450
4613
22
49
428
4500
17
121
392
4025
Inpatient Hospital
21 [8717]
2.5e-02
1.4e+00
2.1e+00
—
2.1e+00
8.1e-01
5.1e-01
cases:27.16%
controls:26.67%
cases:27.59%
controls:8.41%
cases:8.62%
controls:1.10%
—
—
cases:8.21%
controls:1.06%
cases:16.89%
controls:8.27%
cases:31.54%
controls:21.64%
126
1233
338
3390
128
389
336
4234
40
51
424
4572
—
38
49
425
4571
76
376
374
4173
129
897
280
3249
Thorax CT examination
GD1AD [2001303618]
1.2e+00
2.7e+00
1.0e+50
—
—
2.5e+00
1.7e+00
cases:1.08%
controls:0.32%
cases:3.23%
controls:0.22%
cases:1.29%
controls:0.00%
—
—
—
—
cases:2.89%
controls:0.24%
cases:3.91%
controls:0.72%
5
15
459
4608
15
10
449
4613
6
0
458
4623
—
—
13
11
437
4538
16
30
393
4116
General anaesthesia
WX402 [2001310806]
1.6e-01
2.1e+00
—
1.0e+50
2.5e+00
1.6e+00
7.8e-01
cases:1.29%
controls:1.10%
cases:6.68%
controls:0.91%
—
—
cases:4.96%
controls:0.00%
cases:1.51%
controls:0.13%
cases:4.00%
controls:0.84%
cases:6.11%
controls:2.89%
6
51
458
4572
31
42
433
4581
—
23
0
441
4623
7
6
456
4614
18
38
432
4511
25
120
384
4026
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
-4.1e-01
2.1e+00
3.4e+00
—
—
1.3e+00
5.4e-01
cases:2.16%
controls:3.20%
cases:8.19%
controls:1.04%
cases:3.23%
controls:0.11%
—
—
—
—
cases:4.44%
controls:1.30%
cases:6.11%
controls:3.67%
10
148
454
4475
38
48
426
4575
15
5
449
4618
—
—
20
59
430
4490
25
152
384
3994
CBC panel - Blood by Automated count
58410-2 [40761511]
2.8e-03
5.5e-01
2.0e+00
2.7e+00
1.6e+00
3.5e-01
2.1e-01
cases:26.29%
controls:26.24%
cases:27.80%
controls:18.21%
cases:18.10%
controls:2.92%
cases:3.02%
controls:0.22%
cases:13.82%
controls:3.16%
cases:23.33%
controls:17.72%
cases:39.85%
controls:34.90%
122
1213
342
3410
129
842
335
3781
84
135
380
4488
14
10
450
4613
64
146
399
4474
105
806
345
3743
163
1447
246
2699
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.1e-02
6.3e-01
1.6e+00
3.2e+00
1.2e+00
2.1e-01
6.7e-02
cases:26.94%
controls:26.52%
cases:32.97%
controls:20.83%
cases:16.38%
controls:3.63%
cases:4.74%
controls:0.19%
cases:11.88%
controls:3.94%
cases:25.33%
controls:21.52%
cases:41.32%
controls:39.70%
125
1226
339
3397
153
963
311
3660
76
168
388
4455
22
9
442
4614
55
182
408
4438
114
979
336
3570
169
1646
240
2500
Upper gastrointestinal surgery
106 [44777669]
9.3e-02
1.2e+00
1.7e+00
1.0e+50
2.2e+00
9.4e-01
6.8e-01
cases:7.76%
controls:7.12%
cases:8.41%
controls:2.79%
cases:1.94%
controls:0.35%
cases:1.08%
controls:0.00%
cases:3.46%
controls:0.41%
cases:7.33%
controls:3.01%
cases:15.40%
controls:8.47%
36
329
428
4294
39
129
425
4494
9
16
455
4607
5
0
459
4623
16
19
447
4601
33
137
417
4412
63
351
346
3795
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.8e-02
6.1e-01
1.6e+00
3.2e+00
1.2e+00
2.1e-01
7.7e-02
cases:27.16%
controls:26.80%
cases:32.97%
controls:21.16%
cases:16.59%
controls:3.74%
cases:4.53%
controls:0.19%
cases:12.10%
controls:4.00%
cases:25.78%
controls:21.89%
cases:41.81%
controls:39.94%
126
1239
338
3384
153
978
311
3645
77
173
387
4450
21
9
443
4614
56
185
407
4435
116
996
334
3553
171
1656
238
2490
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
2.0e-01
9.8e-01
1.7e+00
—
3.3e+00
7.2e-01
6.1e-01
cases:8.41%
controls:6.97%
cases:6.68%
controls:2.62%
cases:3.23%
controls:0.63%
—
—
cases:11.88%
controls:0.48%
cases:5.11%
controls:2.55%
cases:12.47%
controls:7.21%
39
322
425
4301
31
121
433
4502
15
29
449
4594
—
55
22
408
4598
23
116
427
4433
51
299
358
3847
Multidisciplinary treatment meeting
WZC20 [2001310890]
—
3.6e+00
1.0e+50
—
—
2.9e+00
1.5e+00
—
—
cases:3.88%
controls:0.11%
cases:1.94%
controls:0.00%
—
—
—
—
cases:2.00%
controls:0.11%
cases:1.22%
controls:0.27%
—
18
5
446
4618
9
0
455
4623
—
—
9
5
441
4544
5
11
404
4135
Office Visit
OMOP4822458 [581477]
2.0e-01
1.2e+00
2.1e+00
1.0e+50
2.2e+00
1.0e+00
5.5e-01
cases:8.84%
controls:7.33%
cases:6.47%
controls:2.01%
cases:2.59%
controls:0.32%
cases:2.59%
controls:0.00%
cases:1.73%
controls:0.19%
cases:4.44%
controls:1.65%
cases:8.31%
controls:4.97%
41
339
423
4284
30
93
434
4530
12
15
452
4608
12
0
452
4623
8
9
455
4611
20
75
430
4474
34
206
375
3940
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-5.4e-02
1.3e+00
2.4e+00
—
1.4e+00
9.0e-01
4.5e-01
cases:9.27%
controls:9.73%
cases:16.59%
controls:5.06%
cases:6.68%
controls:0.63%
—
—
cases:3.02%
controls:0.76%
cases:10.89%
controls:4.73%
cases:19.56%
controls:13.39%
43
450
421
4173
77
234
387
4389
31
29
433
4594
—
14
35
449
4585
49
215
401
4334
80
555
329
3591
INR in Blood by Coagulation assay
34714-6 [3032080]
7.7e-02
1.7e+00
2.4e+00
—
1.3e+00
1.0e+00
4.4e-01
cases:8.41%
controls:7.83%
cases:22.20%
controls:4.85%
cases:13.58%
controls:1.38%
—
—
cases:5.62%
controls:1.60%
cases:11.33%
controls:4.48%
cases:17.11%
controls:11.70%
39
362
425
4261
103
224
361
4399
63
64
401
4559
—
26
74
437
4546
51
204
399
4345
70
485
339
3661
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
-1.3e-01
1.2e+00
2.1e+00
—
2.3e+00
8.4e-01
3.2e-01
cases:5.82%
controls:6.60%
cases:11.42%
controls:3.76%
cases:4.74%
controls:0.61%
—
—
cases:4.97%
controls:0.54%
cases:8.00%
controls:3.63%
cases:13.45%
controls:10.11%
27
305
437
4318
53
174
411
4449
22
28
442
4595
—
23
25
440
4595
36
165
414
4384
55
419
354
3727
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
-1.2e-01
1.8e+00
3.3e+00
1.0e+50
—
1.2e+00
6.0e-01
cases:4.31%
controls:4.82%
cases:10.13%
controls:1.82%
cases:5.17%
controls:0.19%
cases:1.51%
controls:0.00%
—
—
cases:5.33%
controls:1.63%
cases:9.29%
controls:5.33%
20
223
444
4400
47
84
417
4539
24
9
440
4614
7
0
457
4623
—
24
74
426
4475
38
221
371
3925
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
7.8e-01
3.7e+00
—
—
—
2.5e+00
1.2e+00
cases:1.08%
controls:0.50%
cases:4.96%
controls:0.13%
—
—
—
—
—
—
cases:3.33%
controls:0.29%
cases:2.69%
controls:0.84%
5
23
459
4600
23
6
441
4617
—
—
—
15
13
435
4536
11
35
398
4111
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
-1.8e-02
1.7e+00
3.4e+00
1.0e+50
1.3e+00
1.1e+00
2.4e-01
cases:6.47%
controls:6.58%
cases:14.22%
controls:3.05%
cases:8.84%
controls:0.32%
cases:2.16%
controls:0.00%
cases:1.94%
controls:0.54%
cases:7.33%
controls:2.57%
cases:10.76%
controls:8.63%
30
304
434
4319
66
141
398
4482
41
15
423
4608
10
0
454
4623
9
25
454
4595
33
117
417
4432
44
358
365
3788
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
3.6e-02
6.3e-01
1.7e+00
2.7e+00
1.1e+00
3.0e-01
1.0e-01
cases:29.53%
controls:28.79%
cases:37.72%
controls:24.31%
cases:22.41%
controls:5.00%
cases:3.45%
controls:0.24%
cases:13.39%
controls:4.94%
cases:31.11%
controls:24.99%
cases:45.48%
controls:42.98%
137
1331
327
3292
175
1124
289
3499
104
231
360
4392
16
11
448
4612
62
228
401
4392
140
1137
310
3412
186
1782
223
2364
Platelets [#/volume] in Blood
26515-7 [3007461]
-2.1e-02
4.8e-01
1.8e+00
2.4e+00
1.2e+00
2.1e-01
7.2e-02
cases:30.17%
controls:30.61%
cases:36.64%
controls:26.39%
cases:25.86%
controls:5.56%
cases:3.66%
controls:0.35%
cases:17.28%
controls:5.67%
cases:31.56%
controls:27.15%
cases:47.43%
controls:45.63%
140
1415
324
3208
170
1220
294
3403
120
257
344
4366
17
16
447
4607
80
262
383
4358
142
1235
308
3314
194
1892
215
2254
MCH [Entitic mass]
28539-5 [3035941]
-2.3e-02
4.8e-01
1.8e+00
2.4e+00
1.2e+00
2.2e-01
6.2e-02
cases:30.17%
controls:30.65%
cases:36.64%
controls:26.41%
cases:25.86%
controls:5.58%
cases:3.66%
controls:0.35%
cases:17.28%
controls:5.69%
cases:31.78%
controls:27.17%
cases:47.19%
controls:45.63%
140
1417
324
3206
170
1221
294
3402
120
258
344
4365
17
16
447
4607
80
263
383
4357
143
1236
307
3313
193
1892
216
2254
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-2.4e-02
4.7e-01
1.8e+00
2.4e+00
1.2e+00
2.2e-01
6.8e-02
cases:30.17%
controls:30.67%
cases:36.64%
controls:26.45%
cases:25.86%
controls:5.58%
cases:3.66%
controls:0.35%
cases:17.28%
controls:5.69%
cases:31.78%
controls:27.24%
cases:47.43%
controls:45.73%
140
1418
324
3205
170
1223
294
3400
120
258
344
4365
17
16
447
4607
80
263
383
4357
143
1239
307
3310
194
1896
215
2250
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-2.4e-02
4.7e-01
1.8e+00
2.4e+00
1.2e+00
2.2e-01
7.0e-02
cases:30.17%
controls:30.67%
cases:36.64%
controls:26.48%
cases:25.86%
controls:5.56%
cases:3.66%
controls:0.35%
cases:17.28%
controls:5.71%
cases:31.78%
controls:27.19%
cases:47.43%
controls:45.68%
140
1418
324
3205
170
1224
294
3399
120
257
344
4366
17
16
447
4607
80
264
383
4356
143
1237
307
3312
194
1894
215
2252
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-2.4e-02
4.7e-01
1.8e+00
2.4e+00
1.2e+00
2.2e-01
7.0e-02
cases:30.17%
controls:30.67%
cases:36.64%
controls:26.48%
cases:25.86%
controls:5.58%
cases:3.66%
controls:0.35%
cases:17.28%
controls:5.69%
cases:31.78%
controls:27.21%
cases:47.43%
controls:45.68%
140
1418
324
3205
170
1224
294
3399
120
258
344
4365
17
16
447
4607
80
263
383
4357
143
1238
307
3311
194
1894
215
2252
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-2.3e-02
4.7e-01
1.8e+00
2.4e+00
1.2e+00
2.2e-01
7.1e-02
cases:30.17%
controls:30.65%
cases:36.64%
controls:26.45%
cases:25.86%
controls:5.58%
cases:3.66%
controls:0.35%
cases:17.28%
controls:5.71%
cases:31.78%
controls:27.21%
cases:47.43%
controls:45.66%
140
1417
324
3206
170
1223
294
3400
120
258
344
4365
17
16
447
4607
80
264
383
4356
143
1238
307
3311
194
1893
215
2253
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-2.6e-02
4.8e-01
1.8e+00
2.4e+00
1.2e+00
2.2e-01
7.0e-02
cases:30.17%
controls:30.72%
cases:36.85%
controls:26.52%
cases:25.86%
controls:5.60%
cases:3.66%
controls:0.35%
cases:17.28%
controls:5.74%
cases:31.78%
controls:27.28%
cases:47.43%
controls:45.68%
140
1420
324
3203
171
1226
293
3397
120
259
344
4364
17
16
447
4607
80
265
383
4355
143
1241
307
3308
194
1894
215
2252
Laboratory Visit
OMOP4822461 [32036]
4.1e-03
3.6e-01
1.4e+00
3.1e+00
9.1e-01
1.6e-01
1.4e-01
cases:33.84%
controls:33.74%
cases:40.30%
controls:31.95%
cases:32.11%
controls:9.99%
cases:11.21%
controls:0.56%
cases:21.60%
controls:10.00%
cases:37.11%
controls:33.48%
cases:52.32%
controls:48.91%
157
1560
307
3063
187
1477
277
3146
149
462
315
4161
52
26
412
4597
100
462
363
4158
167
1523
283
3026
214
2028
195
2118
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
—
3.2e+00
1.0e+50
1.0e+50
—
2.4e+00
5.8e-01
—
—
cases:5.82%
controls:0.26%
cases:1.29%
controls:0.00%
cases:1.29%
controls:0.00%
—
—
cases:3.11%
controls:0.29%
cases:1.96%
controls:1.11%
—
27
12
437
4611
6
0
458
4623
6
0
458
4623
—
14
13
436
4536
8
46
401
4100
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
—
2.1e+00
—
—
2.2e+00
1.3e+00
4.6e-01
—
—
cases:5.39%
controls:0.67%
—
—
—
—
cases:1.30%
controls:0.15%
cases:2.89%
controls:0.84%
cases:4.40%
controls:2.82%
—
25
31
439
4592
—
—
6
7
457
4613
13
38
437
4511
18
117
391
4029
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
-8.7e-02
1.8e+00
2.7e+00
—
2.0e+00
9.7e-01
5.0e-01
cases:3.88%
controls:4.22%
cases:10.99%
controls:2.03%
cases:3.88%
controls:0.26%
—
—
cases:1.08%
controls:0.15%
cases:4.22%
controls:1.65%
cases:7.58%
controls:4.75%
18
195
446
4428
51
94
413
4529
18
12
446
4611
—
5
7
458
4613
19
75
431
4474
31
197
378
3949
Pathology report gross observation
24419-4 [3002256]
-2.4e-01
2.4e+00
—
1.0e+50
—
1.7e+00
9.9e-01
cases:1.51%
controls:1.90%
cases:5.82%
controls:0.54%
—
—
cases:1.94%
controls:0.00%
—
—
cases:2.00%
controls:0.37%
cases:4.89%
controls:1.88%
7
88
457
4535
27
25
437
4598
—
9
0
455
4623
—
9
17
441
4532
20
78
389
4068
Cathetrisation of artery
TPH07 [2001309747]
—
2.9e+00
1.0e+50
1.0e+50
—
2.2e+00
4.8e-01
—
—
cases:6.25%
controls:0.37%
cases:1.08%
controls:0.00%
cases:1.94%
controls:0.00%
—
—
cases:2.44%
controls:0.29%
cases:1.71%
controls:1.06%
—
29
17
435
4606
5
0
459
4623
9
0
455
4623
—
11
13
439
4536
7
44
402
4102
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
—
2.7e+00
—
1.0e+50
—
2.2e+00
2.7e-01
—
—
cases:6.25%
controls:0.45%
—
—
cases:1.51%
controls:0.00%
—
—
cases:4.22%
controls:0.48%
cases:2.69%
controls:2.07%
—
29
21
435
4602
—
7
0
457
4623
—
19
22
431
4527
11
86
398
4060
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
—
3.0e+00
—
—
—
1.9e+00
—
—
—
cases:4.09%
controls:0.22%
—
—
—
—
—
—
cases:2.44%
controls:0.37%
—
—
—
19
10
445
4613
—
—
—
11
17
439
4532
—
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
—
3.1e+00
—
—
—
1.7e+00
—
—
—
cases:4.31%
controls:0.19%
—
—
—
—
—
—
cases:2.44%
controls:0.44%
—
—
—
20
9
444
4614
—
—
—
11
20
439
4529
—
One hour or less
ZXE00 [2001311394]
3.6e-01
1.5e+00
2.1e+00
1.0e+50
—
9.0e-01
1.3e+00
cases:7.11%
controls:5.06%
cases:4.31%
controls:0.97%
cases:1.51%
controls:0.19%
cases:8.84%
controls:0.00%
—
—
cases:2.67%
controls:1.10%
cases:10.51%
controls:3.18%
33
234
431
4389
20
45
444
4578
7
9
457
4614
41
0
423
4623
—
12
50
438
4499
43
132
366
4014
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
—
3.0e+00
—
—
—
1.8e+00
—
—
—
cases:4.31%
controls:0.22%
—
—
—
—
—
—
cases:2.44%
controls:0.42%
—
—
—
20
10
444
4613
—
—
—
11
19
439
4530
—
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
—
2.6e+00
—
1.0e+50
—
2.2e+00
6.2e-01
—
—
cases:6.90%
controls:0.54%
—
—
cases:7.54%
controls:0.00%
—
—
cases:3.33%
controls:0.40%
cases:3.67%
controls:2.00%
—
32
25
432
4598
—
35
0
429
4623
—
15
18
435
4531
15
83
394
4063
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
—
3.0e+00
—
—
—
1.8e+00
—
—
—
cases:4.09%
controls:0.22%
—
—
—
—
—
—
cases:2.44%
controls:0.42%
—
—
—
19
10
445
4613
—
—
—
11
19
439
4530
—
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
6.4e-01
3.0e+00
—
—
—
1.7e+00
9.5e-01
cases:3.23%
controls:1.73%
cases:8.84%
controls:0.48%
—
—
—
—
—
—
cases:2.67%
controls:0.48%
cases:3.42%
controls:1.35%
15
80
449
4543
41
22
423
4601
—
—
—
12
22
438
4527
14
56
395
4090
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-6.0e-02
1.2e+00
1.5e+00
—
1.5e+00
6.4e-01
5.2e-01
cases:6.47%
controls:6.84%
cases:12.28%
controls:3.92%
cases:2.80%
controls:0.65%
—
—
cases:2.16%
controls:0.50%
cases:6.89%
controls:3.76%
cases:15.65%
controls:9.96%
30
316
434
4307
57
181
407
4442
13
30
451
4593
—
10
23
453
4597
31
171
419
4378
64
413
345
3733
Oxygen saturation in Arterial blood
2708-6 [3016502]
—
2.6e+00
—
1.0e+50
—
2.0e+00
3.2e-01
—
—
cases:6.47%
controls:0.50%
—
—
cases:1.51%
controls:0.00%
—
—
cases:4.22%
controls:0.62%
cases:2.93%
controls:2.15%
—
30
23
434
4600
—
7
0
457
4623
—
19
28
431
4521
12
89
397
4057
Thoracal epidural anesthesia
WX302 [2001310795]
—
2.6e+00
1.0e+50
1.0e+50
—
—
1.9e+00
—
—
cases:1.51%
controls:0.11%
cases:1.08%
controls:0.00%
cases:1.94%
controls:0.00%
—
—
—
—
cases:2.20%
controls:0.34%
—
7
5
457
4618
5
0
459
4623
9
0
455
4623
—
—
9
14
400
4132
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.0e-01
7.9e-01
8.7e-01
-1.0e+50
2.2e+00
6.1e-01
3.4e-01
cases:31.47%
controls:27.36%
cases:28.45%
controls:15.31%
cases:6.90%
controls:3.01%
cases:0.00%
controls:0.15%
cases:18.14%
controls:2.45%
cases:25.78%
controls:15.83%
cases:40.83%
controls:32.92%
146
1265
318
3358
132
708
332
3915
32
139
432
4484
0
7
464
4616
84
113
379
4507
116
720
334
3829
167
1365
242
2781
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
9.5e-01
1.7e+00
—
—
—
1.6e+00
1.1e+00
cases:3.23%
controls:1.28%
cases:2.59%
controls:0.50%
—
—
—
—
—
—
cases:1.78%
controls:0.35%
cases:5.13%
controls:1.71%
15
59
449
4564
12
23
452
4600
—
—
—
8
16
442
4533
21
71
388
4075
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.1e-02
1.1e+00
1.3e+00
—
8.5e-01
7.4e-01
4.2e-01
cases:15.52%
controls:15.12%
cases:25.86%
controls:10.30%
cases:6.47%
controls:1.82%
—
—
cases:4.54%
controls:1.99%
cases:18.89%
controls:10.02%
cases:30.56%
controls:22.46%
72
699
392
3924
120
476
344
4147
30
84
434
4539
—
21
92
442
4528
85
456
365
4093
125
931
284
3215
Normoblasts [#/volume] in Blood
715-3 [3021589]
5.8e-02
7.8e-01
1.5e+00
1.0e+50
1.6e+00
5.4e-01
5.5e-01
cases:6.90%
controls:6.53%
cases:11.42%
controls:5.60%
cases:5.39%
controls:1.25%
cases:1.08%
controls:0.00%
cases:4.75%
controls:1.04%
cases:9.33%
controls:5.67%
cases:19.56%
controls:12.28%
32
302
432
4321
53
259
411
4364
25
58
439
4565
5
0
459
4623
22
48
441
4572
42
258
408
4291
80
509
329
3637
pH of Arterial blood
2744-1 [3019977]
2.9e-01
2.5e+00
—
1.0e+50
—
1.8e+00
3.8e-01
cases:1.29%
controls:0.97%
cases:6.25%
controls:0.52%
—
—
cases:1.51%
controls:0.00%
—
—
cases:3.78%
controls:0.66%
cases:3.42%
controls:2.36%
6
45
458
4578
29
24
435
4599
—
7
0
457
4623
—
17
30
433
4519
14
98
395
4048
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
3.1e-01
2.5e+00
—
1.0e+50
—
1.8e+00
4.3e-01
cases:1.29%
controls:0.95%
cases:6.25%
controls:0.52%
—
—
cases:1.51%
controls:0.00%
—
—
cases:3.78%
controls:0.66%
cases:3.42%
controls:2.24%
6
44
458
4579
29
24
435
4599
—
7
0
457
4623
—
17
30
433
4519
14
93
395
4053
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
3.1e-01
2.5e+00
—
1.0e+50
—
1.8e+00
4.3e-01
cases:1.29%
controls:0.95%
cases:6.25%
controls:0.52%
—
—
cases:1.51%
controls:0.00%
—
—
cases:3.78%
controls:0.66%
cases:3.42%
controls:2.24%
6
44
458
4579
29
24
435
4599
—
7
0
457
4623
—
17
30
433
4519
14
93
395
4053
Case Management Agency
251B00000X [38004193]
5.3e-02
2.5e-01
8.0e-01
2.9e+00
5.8e-01
2.1e-01
1.2e-01
cases:54.96%
controls:53.64%
cases:52.59%
controls:46.33%
cases:33.19%
controls:18.30%
cases:21.34%
controls:1.41%
cases:28.51%
controls:18.27%
cases:53.56%
controls:48.38%
cases:67.73%
controls:65.07%
255
2480
209
2143
244
2142
220
2481
154
846
310
3777
99
65
365
4558
132
844
331
3776
241
2201
209
2348
277
2698
132
1448
Gas panel - Venous blood
24339-4 [3000991]
—
2.7e+00
—
—
—
1.6e+00
-1.1e-01
—
—
cases:4.53%
controls:0.32%
—
—
—
—
—
—
cases:2.44%
controls:0.48%
cases:1.47%
controls:1.64%
—
21
15
443
4608
—
—
—
11
22
439
4527
6
68
403
4078
Base excess in Arterial blood by calculation
1925-7 [3003396]
2.9e-01
2.5e+00
—
1.0e+50
—
1.8e+00
2.3e-01
cases:1.29%
controls:0.97%
cases:6.47%
controls:0.56%
—
—
cases:1.51%
controls:0.00%
—
—
cases:3.78%
controls:0.64%
cases:2.93%
controls:2.34%
6
45
458
4578
30
26
434
4597
—
7
0
457
4623
—
17
29
433
4520
12
97
397
4049
12 lead EKG panel
34534-8 [3044889]
1.8e-01
9.4e-01
2.2e+00
—
1.1e+00
4.5e-01
3.7e-01
cases:17.03%
controls:14.60%
cases:18.10%
controls:7.98%
cases:7.76%
controls:0.89%
—
—
cases:3.02%
controls:1.00%
cases:11.33%
controls:7.52%
cases:27.38%
controls:20.65%
79
675
385
3948
84
369
380
4254
36
41
428
4582
—
14
46
449
4574
51
342
399
4207
112
856
297
3290
Emergency Room Visit
ER [9203]
2.0e-01
1.2e+00
1.2e+00
—
1.3e+00
4.6e-01
5.8e-01
cases:30.39%
controls:26.39%
cases:23.28%
controls:8.72%
cases:4.09%
controls:1.25%
—
—
cases:3.46%
controls:0.97%
cases:12.22%
controls:8.11%
cases:33.99%
controls:22.31%
141
1220
323
3403
108
403
356
4220
19
58
445
4565
—
16
45
447
4575
55
369
395
4180
139
925
270
3221
General Surgery
2 [38004447]
3.4e-01
8.6e-01
1.0e+00
—
2.1e+00
6.7e-01
6.0e-01
cases:23.49%
controls:17.91%
cases:12.07%
controls:5.49%
cases:2.80%
controls:1.02%
—
—
cases:5.18%
controls:0.67%
cases:10.22%
controls:5.50%
cases:25.18%
controls:15.61%
109
828
355
3795
56
254
408
4369
13
47
451
4576
—
24
31
439
4589
46
250
404
4299
103
647
306
3499
Medical doctor
Z2221 [2001311556]
2.4e-02
1.1e+00
2.3e+00
—
—
9.7e-01
8.1e-01
cases:4.09%
controls:4.00%
cases:3.66%
controls:1.28%
cases:1.29%
controls:0.13%
—
—
—
—
cases:2.44%
controls:0.95%
cases:5.38%
controls:2.46%
19
185
445
4438
17
59
447
4564
6
6
458
4617
—
—
11
43
439
4506
22
102
387
4044
X-ray examination of the lungs in one projection
GD1PA [2001303645]
—
2.7e+00
1.0e+50
1.0e+50
1.0e+50
1.8e+00
1.4e+00
—
—
cases:3.23%
controls:0.22%
cases:1.29%
controls:0.00%
cases:1.08%
controls:0.00%
cases:1.08%
controls:0.00%
cases:1.33%
controls:0.22%
cases:4.16%
controls:1.06%
—
15
10
449
4613
6
0
458
4623
5
0
459
4623
5
0
458
4620
6
10
444
4539
17
44
392
4102
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
—
2.5e+00
—
—
—
1.6e+00
5.8e-02
—
—
cases:4.31%
controls:0.37%
—
—
—
—
—
—
cases:2.44%
controls:0.51%
cases:1.71%
controls:1.62%
—
20
17
444
4606
—
—
—
11
23
439
4526
7
67
402
4079
Cathetrisation of vein
TPH04 [2001309597]
1.7e-01
1.6e+00
—
—
2.5e+00
3.9e-01
6.2e-01
cases:2.59%
controls:2.18%
cases:5.17%
controls:1.08%
—
—
—
—
cases:1.51%
controls:0.13%
cases:1.56%
controls:1.06%
cases:4.89%
controls:2.70%
12
101
452
4522
24
50
440
4573
—
—
7
6
456
4614
7
48
443
4501
20
112
389
4034
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
D38.1 [45605357]
—
—
1.0e+50
1.0e+50
1.0e+50
—
3.9e+00
—
—
—
—
cases:17.89%
controls:0.00%
cases:5.60%
controls:0.00%
cases:5.40%
controls:0.00%
—
—
cases:5.62%
controls:0.12%
—
—
83
0
381
4623
26
0
438
4623
25
0
438
4620
—
23
5
386
4141
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-2.2e-01
1.1e+00
1.4e+00
—
1.4e+00
6.3e-01
4.3e-01
cases:6.25%
controls:7.64%
cases:12.72%
controls:4.48%
cases:2.80%
controls:0.74%
—
—
cases:2.38%
controls:0.61%
cases:7.78%
controls:4.29%
cases:17.36%
controls:12.01%
29
353
435
4270
59
207
405
4416
13
34
451
4589
—
11
28
452
4592
35
195
415
4354
71
498
338
3648
Bacteria identified in Blood by Culture
600-7 [3023368]
-2.8e-01
1.1e+00
1.8e+00
—
2.8e+00
8.1e-01
5.4e-01
cases:2.37%
controls:3.11%
cases:5.60%
controls:2.01%
cases:1.08%
controls:0.17%
—
—
cases:1.73%
controls:0.11%
cases:2.44%
controls:1.10%
cases:8.56%
controls:5.16%
11
144
453
4479
26
93
438
4530
5
8
459
4615
—
8
5
455
4615
11
50
439
4499
35
214
374
3932
High resolution CT examination of lungs
GD1DD [2001303632]
—
2.2e+00
—
—
—
—
1.6e+00
—
—
cases:1.29%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.39%
—
6
7
458
4616
—
—
—
—
8
16
401
4130
Removal of sutures
SPAT1153 [2001700254]
1.9e-01
4.7e-01
1.5e+00
—
3.8e+00
4.4e-01
4.0e-01
cases:5.39%
controls:4.48%
cases:2.37%
controls:1.49%
cases:1.08%
controls:0.24%
—
—
cases:4.54%
controls:0.11%
cases:2.00%
controls:1.30%
cases:5.87%
controls:4.03%
25
207
439
4416
11
69
453
4554
5
11
459
4612
—
21
5
442
4615
9
59
441
4490
24
167
385
3979
ibuprofen
R02AX02 [1588667]
3.5e-01
4.7e-01
1.0e+00
—
1.9e+00
3.7e-01
3.4e-01
cases:37.93%
controls:30.05%
cases:19.40%
controls:13.02%
cases:5.60%
controls:2.12%
—
—
cases:12.53%
controls:2.03%
cases:18.89%
controls:13.81%
cases:37.65%
controls:30.05%
176
1389
288
3234
90
602
374
4021
26
98
438
4525
—
58
94
405
4526
85
628
365
3921
154
1246
255
2900
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
3.5e-01
4.7e-01
1.0e+00
—
1.9e+00
3.7e-01
3.4e-01
cases:37.93%
controls:30.05%
cases:19.40%
controls:13.02%
cases:5.60%
controls:2.12%
—
—
cases:12.53%
controls:2.03%
cases:18.89%
controls:13.81%
cases:37.65%
controls:30.05%
176
1389
288
3234
90
602
374
4021
26
98
438
4525
—
58
94
405
4526
85
628
365
3921
154
1246
255
2900
tiotropium bromide; inhalant
R03BB04 [21603296]
8.3e-01
1.2e+00
1.4e+00
—
1.3e+00
1.3e+00
1.1e+00
cases:4.53%
controls:2.03%
cases:4.74%
controls:1.41%
cases:1.72%
controls:0.43%
—
—
cases:2.16%
controls:0.58%
cases:4.89%
controls:1.43%
cases:6.60%
controls:2.24%
21
94
443
4529
22
65
442
4558
8
20
456
4603
—
10
27
453
4593
22
65
428
4484
27
93
382
4053
Emergency Medicine
93 [38004510]
2.2e-01
7.3e-01
1.4e+00
—
1.4e+00
4.2e-01
2.3e-01
cases:12.28%
controls:10.14%
cases:12.07%
controls:6.21%
cases:3.02%
controls:0.76%
—
—
cases:3.24%
controls:0.78%
cases:8.44%
controls:5.74%
cases:21.27%
controls:17.68%
57
469
407
4154
56
287
408
4336
14
35
450
4588
—
15
36
448
4584
38
261
412
4288
87
733
322
3413
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
1.2e-01
1.2e+00
1.0e+00
—
7.8e-01
7.0e-01
5.6e-01
cases:9.27%
controls:8.28%
cases:14.87%
controls:4.91%
cases:3.02%
controls:1.08%
—
—
cases:1.73%
controls:0.80%
cases:9.78%
controls:5.12%
cases:18.58%
controls:11.51%
43
383
421
4240
69
227
395
4396
14
50
450
4573
—
8
37
455
4583
44
233
406
4316
76
477
333
3669
salbutamol; inhalant
R03AC02 [21603256]
4.3e-01
9.3e-01
7.0e-01
—
1.3e+00
7.1e-01
5.2e-01
cases:16.81%
controls:11.66%
cases:13.79%
controls:5.95%
cases:2.16%
controls:1.08%
—
—
cases:3.89%
controls:1.04%
cases:11.78%
controls:6.18%
cases:19.80%
controls:12.78%
78
539
386
4084
64
275
400
4348
10
50
454
4573
—
18
48
445
4572
53
281
397
4268
81
530
328
3616
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-8.9e-02
4.9e-01
1.8e+00
1.6e+00
1.1e+00
7.4e-02
-1.5e-01
cases:21.34%
controls:22.86%
cases:26.08%
controls:17.76%
cases:19.18%
controls:3.76%
cases:1.29%
controls:0.26%
cases:10.37%
controls:3.57%
cases:19.56%
controls:18.42%
cases:29.83%
controls:32.97%
99
1057
365
3566
121
821
343
3802
89
174
375
4449
6
12
458
4611
48
165
415
4455
88
838
362
3711
122
1367
287
2779
salmeterol and fluticasone
R03AK06 [21603280]
3.1e-01
7.5e-01
1.1e+00
—
1.5e+00
8.9e-01
1.0e+00
cases:3.23%
controls:2.40%
cases:3.45%
controls:1.67%
cases:1.29%
controls:0.45%
—
—
cases:2.38%
controls:0.56%
cases:4.44%
controls:1.87%
cases:6.11%
controls:2.32%
15
111
449
4512
16
77
448
4546
6
21
458
4602
—
11
26
452
4594
20
85
430
4464
25
96
384
4050
pregabalin; oral
N02BF02 [955152]
5.3e-02
8.8e-01
8.8e-01
—
2.2e+00
1.1e+00
6.4e-02
cases:3.66%
controls:3.48%
cases:3.88%
controls:1.64%
cases:1.29%
controls:0.54%
—
—
cases:4.54%
controls:0.54%
cases:4.44%
controls:1.56%
cases:3.67%
controls:3.45%
17
161
447
4462
18
76
446
4547
6
25
458
4598
—
21
25
442
4595
20
71
430
4478
15
143
394
4003
Intravenous general anesthesia
WX404 [2001310807]
-4.9e-01
1.6e+00
—
1.0e+50
—
—
1.6e+00
cases:1.72%
controls:2.79%
cases:2.80%
controls:0.58%
—
—
cases:3.45%
controls:0.00%
—
—
—
—
cases:5.62%
controls:1.16%
8
129
456
4494
13
27
451
4596
—
16
0
448
4623
—
—
23
48
386
4098
cefalexin; oral
J01DB01 [21602870]
2.5e-01
7.5e-01
9.5e-01
—
1.9e+00
2.6e-01
5.1e-01
cases:28.02%
controls:23.32%
cases:14.44%
controls:7.40%
cases:2.59%
controls:1.02%
—
—
cases:6.05%
controls:0.91%
cases:9.78%
controls:7.74%
cases:33.50%
controls:23.23%
130
1078
334
3545
67
342
397
4281
12
47
452
4576
—
28
42
435
4578
44
352
406
4197
137
963
272
3183
Diffusion capacity of lung
54715006 [4182985]
—
3.2e+00
—
—
—
—
—
—
—
cases:3.45%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
16
7
448
4616
—
—
—
—
—
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
8.8e-02
6.4e-01
1.4e+00
—
1.1e+00
3.5e-01
2.3e-01
cases:21.34%
controls:19.90%
cases:27.59%
controls:16.74%
cases:12.72%
controls:3.44%
—
—
cases:9.29%
controls:3.33%
cases:23.56%
controls:17.78%
cases:37.65%
controls:32.34%
99
920
365
3703
128
774
336
3849
59
159
405
4464
—
43
154
420
4466
106
809
344
3740
154
1341
255
2805
Mycobacterium sp identified in Specimen
40699-1 [3042631]
—
—
—
—
1.0e+50
—
3.1e+00
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.00%
—
—
cases:2.69%
controls:0.12%
—
—
—
—
5
0
458
4620
—
11
5
398
4141
Extensive body CT
JN4BD [2001310899]
5.3e-01
1.6e+00
—
—
—
1.6e+00
1.5e+00
cases:1.94%
controls:1.15%
cases:2.16%
controls:0.43%
—
—
—
—
—
—
cases:1.11%
controls:0.22%
cases:3.18%
controls:0.72%
9
53
455
4570
10
20
454
4603
—
—
—
5
10
445
4539
13
30
396
4116
Myalgia
M79.1 [45587062]
1.2e+00
—
—
—
—
2.0e+00
6.8e-01
cases:3.02%
controls:0.97%
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.22%
cases:3.18%
controls:1.64%
14
45
450
4578
—
—
—
—
7
10
443
4539
13
68
396
4078
Enolase.neuron specific [Mass/volume] in Serum or Plasma
15060-7 [3028531]
-1.0e+50
3.0e+00
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:2.59%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
0
8
464
4615
12
6
452
4617
—
—
—
—
—
dalteparin; parenteral
B01AB04 [21600975]
—
3.0e+00
—
—
—
—
—
—
—
cases:2.16%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
10
5
454
4618
—
—
—
—
—
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
1.7e-02
1.1e+00
1.3e+00
—
1.1e+00
6.2e-01
2.8e-01
cases:15.30%
controls:15.08%
cases:20.04%
controls:7.70%
cases:3.45%
controls:0.97%
—
—
cases:2.38%
controls:0.80%
cases:13.11%
controls:7.52%
cases:24.94%
controls:20.07%
71
697
393
3926
93
356
371
4267
16
45
448
4578
—
11
37
452
4583
59
342
391
4207
102
832
307
3314
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
7.2e-01
1.4e+00
—
—
—
2.9e+00
7.2e-01
cases:2.59%
controls:1.28%
cases:1.08%
controls:0.28%
—
—
—
—
—
—
cases:2.44%
controls:0.13%
cases:2.93%
controls:1.45%
12
59
452
4564
5
13
459
4610
—
—
—
11
6
439
4543
12
60
397
4086
Physiotherapist
Z3226 [2001311560]
1.2e-01
1.6e+00
—
1.0e+50
—
—
1.3e+00
cases:2.16%
controls:1.93%
cases:2.37%
controls:0.48%
—
—
cases:4.31%
controls:0.00%
—
—
—
—
cases:4.40%
controls:1.28%
10
89
454
4534
11
22
453
4601
—
20
0
444
4623
—
—
18
53
391
4093
Pneumonia, unspecified
J18.9 [45601123]
2.9e-01
2.0e+00
—
—
—
7.8e-01
9.2e-01
cases:2.59%
controls:1.95%
cases:6.03%
controls:0.89%
—
—
—
—
—
—
cases:2.00%
controls:0.92%
cases:8.07%
controls:3.38%
12
90
452
4533
28
41
436
4582
—
—
—
9
42
441
4507
33
140
376
4006
Immunohistochemistry procedure
117617002 [4035726]
2.0e-01
1.5e+00
—
—
—
—
1.3e+00
cases:1.29%
controls:1.06%
cases:2.59%
controls:0.56%
—
—
—
—
—
—
—
—
cases:3.42%
controls:0.92%
6
49
458
4574
12
26
452
4597
—
—
—
—
14
38
395
4108
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
1.6e-01
1.5e+00
1.7e+00
—
—
1.4e+00
6.3e-01
cases:1.72%
controls:1.47%
cases:4.53%
controls:1.04%
cases:1.08%
controls:0.19%
—
—
—
—
cases:3.11%
controls:0.81%
cases:3.91%
controls:2.12%
8
68
456
4555
21
48
443
4575
5
9
459
4614
—
—
14
37
436
4512
16
88
393
4058
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.3e-01
1.3e+00
1.1e+00
—
1.1e+00
9.7e-01
6.4e-01
cases:6.68%
controls:5.36%
cases:11.42%
controls:3.53%
cases:2.59%
controls:0.84%
—
—
cases:1.94%
controls:0.67%
cases:8.00%
controls:3.19%
cases:13.45%
controls:7.60%
31
248
433
4375
53
163
411
4460
12
39
452
4584
—
9
31
454
4589
36
145
414
4404
55
315
354
3831
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
—
2.8e+00
—
—
—
—
—
—
—
cases:2.37%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
11
7
453
4616
—
—
—
—
—
Cough
R05 [45606792]
9.3e-01
1.8e+00
—
—
—
1.0e+00
7.2e-01
cases:4.53%
controls:1.84%
cases:3.66%
controls:0.63%
—
—
—
—
—
—
cases:2.22%
controls:0.81%
cases:5.62%
controls:2.82%
21
85
443
4538
17
29
447
4594
—
—
—
10
37
440
4512
23
117
386
4029
Dyspnoea
R06.0 [45558449]
6.0e-01
1.5e+00
2.3e+00
—
—
1.2e+00
3.6e-01
cases:4.31%
controls:2.42%
cases:4.31%
controls:1.02%
cases:1.08%
controls:0.11%
—
—
—
—
cases:3.56%
controls:1.06%
cases:5.38%
controls:3.81%
20
112
444
4511
20
47
444
4576
5
5
459
4618
—
—
16
48
434
4501
22
158
387
3988
Laceration/cut
S18 [2002000983]
-3.9e-03
-1.9e-02
1.6e+00
—
2.7e+00
5.2e-01
1.1e-01
cases:6.25%
controls:6.27%
cases:2.80%
controls:2.86%
cases:1.72%
controls:0.37%
—
—
cases:4.54%
controls:0.32%
cases:4.22%
controls:2.55%
cases:9.78%
controls:8.88%
29
290
435
4333
13
132
451
4491
8
17
456
4606
—
21
15
442
4605
19
116
431
4433
40
368
369
3778
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
-8.3e-02
8.0e-01
—
—
2.6e+00
5.9e-01
2.0e-01
cases:4.09%
controls:4.43%
cases:2.80%
controls:1.28%
—
—
—
—
cases:2.38%
controls:0.17%
cases:2.67%
controls:1.49%
cases:5.38%
controls:4.44%
19
205
445
4418
13
59
451
4564
—
—
11
8
452
4612
12
68
438
4481
22
184
387
3962
Pharmacy visit
OMOP4822462 [581458]
1.4e-02
5.4e-01
6.2e-01
5.3e-01
1.0e+00
4.5e-01
2.9e-01
cases:80.82%
controls:80.60%
cases:83.19%
controls:74.26%
cases:56.25%
controls:40.82%
cases:3.23%
controls:1.93%
cases:66.31%
controls:41.95%
cases:84.00%
controls:76.98%
cases:91.69%
controls:89.19%
375
3726
89
897
386
3433
78
1190
261
1887
203
2736
15
89
449
4534
307
1938
156
2682
378
3502
72
1047
375
3698
34
448
Extensive abdominal CT
JN3BD [2001305556]
—
2.6e+00
—
—
—
—
1.1e+00
—
—
cases:1.72%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.65%
—
8
6
456
4617
—
—
—
—
8
27
401
4119
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
1.3e-01
1.3e+00
1.0e+00
—
1.1e+00
7.6e-01
5.7e-01
cases:9.70%
controls:8.65%
cases:15.73%
controls:5.02%
cases:3.02%
controls:1.12%
—
—
cases:2.59%
controls:0.84%
cases:10.22%
controls:5.03%
cases:19.07%
controls:11.72%
45
400
419
4223
73
232
391
4391
14
52
450
4571
—
12
39
451
4581
46
229
404
4320
78
486
331
3660
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
2.4e-01
1.6e+00
1.6e+00
—
1.3e+00
1.0e+00
1.4e-01
cases:6.68%
controls:5.32%
cases:12.28%
controls:2.83%
cases:1.51%
controls:0.30%
—
—
cases:1.51%
controls:0.43%
cases:6.67%
controls:2.55%
cases:9.05%
controls:7.96%
31
246
433
4377
57
131
407
4492
7
14
457
4609
—
7
20
456
4600
30
116
420
4433
37
330
372
3816
Basophils/Leukocytes in Blood
30180-4 [3022096]
9.5e-02
1.2e+00
9.9e-01
—
1.1e+00
7.4e-01
5.8e-01
cases:9.27%
controls:8.50%
cases:15.30%
controls:4.98%
cases:3.02%
controls:1.15%
—
—
cases:2.59%
controls:0.87%
cases:10.00%
controls:5.06%
cases:18.58%
controls:11.34%
43
393
421
4230
71
230
393
4393
14
53
450
4570
—
12
40
451
4580
45
230
405
4319
76
470
333
3676
Monocytes/Leukocytes in Blood
26485-3 [3019069]
9.2e-02
1.2e+00
1.0e+00
—
1.1e+00
7.2e-01
5.8e-01
cases:9.27%
controls:8.52%
cases:15.30%
controls:4.98%
cases:3.02%
controls:1.12%
—
—
cases:2.59%
controls:0.84%
cases:9.78%
controls:4.99%
cases:18.58%
controls:11.29%
43
394
421
4229
71
230
393
4393
14
52
450
4571
—
12
39
451
4581
44
227
406
4322
76
468
333
3678
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
1.2e-01
1.2e+00
9.9e-01
—
1.1e+00
7.2e-01
5.9e-01
cases:9.48%
controls:8.50%
cases:15.30%
controls:4.98%
cases:3.02%
controls:1.15%
—
—
cases:2.59%
controls:0.87%
cases:9.78%
controls:5.03%
cases:18.58%
controls:11.24%
44
393
420
4230
71
230
393
4393
14
53
450
4570
—
12
40
451
4580
44
229
406
4320
76
466
333
3680
Anion gap in Blood by calculation
41276-7 [3039000]
—
2.5e+00
—
1.0e+50
—
—
—
—
—
cases:1.51%
controls:0.13%
—
—
cases:1.29%
controls:0.00%
—
—
—
—
—
—
—
7
6
457
4617
—
6
0
458
4623
—
—
—
Chloride [Moles/volume] in Blood
2069-3 [3018572]
—
2.5e+00
—
1.0e+50
—
—
—
—
—
cases:1.51%
controls:0.13%
—
—
cases:1.29%
controls:0.00%
—
—
—
—
—
—
—
7
6
457
4617
—
6
0
458
4623
—
—
—
pantoprazole; oral, parenteral
A02BC02 [21600097]
4.8e-01
6.5e-01
1.7e-01
—
1.3e+00
5.1e-01
2.8e-01
cases:20.91%
controls:14.06%
cases:14.01%
controls:7.85%
cases:1.94%
controls:1.64%
—
—
cases:5.40%
controls:1.52%
cases:12.44%
controls:7.89%
cases:20.78%
controls:16.55%
97
650
367
3973
65
363
399
4260
9
76
455
4547
—
25
70
438
4550
56
359
394
4190
85
686
324
3460
Scheduled procedure
ZXD10 [2001311387]
9.6e-02
1.5e+00
2.0e+00
—
—
1.1e+00
9.1e-01
cases:6.25%
controls:5.71%
cases:4.74%
controls:1.10%
cases:1.08%
controls:0.15%
—
—
—
—
cases:2.67%
controls:0.90%
cases:8.56%
controls:3.62%
29
264
435
4359
22
51
442
4572
5
7
459
4616
—
—
12
41
438
4508
35
150
374
3996
Asthma, unspecified
J45.9 [45562456]
1.5e-02
1.1e+00
1.5e+00
1.0e+50
-1.0e+50
1.3e+00
6.3e-01
cases:2.37%
controls:2.34%
cases:3.45%
controls:1.15%
cases:1.29%
controls:0.30%
cases:1.29%
controls:0.00%
cases:0.00%
controls:0.19%
cases:4.00%
controls:1.17%
cases:6.11%
controls:3.35%
11
108
453
4515
16
53
448
4570
6
14
458
4609
6
0
458
4623
0
9
463
4611
18
53
432
4496
25
139
384
4007
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.3e+00
—
—
—
—
—
2.3e+00
cases:1.08%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.14%
5
14
459
4609
—
—
—
—
—
6
6
403
4140
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
1.3e+00
—
—
—
—
—
2.3e+00
cases:1.08%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.14%
5
14
459
4609
—
—
—
—
—
6
6
403
4140
Base excess in Blood by calculation
11555-0 [3012501]
1.3e+00
—
—
—
—
—
2.3e+00
cases:1.08%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.14%
5
14
459
4609
—
—
—
—
—
6
6
403
4140
Lactate [Moles/volume] in Blood
32693-4 [3047181]
—
2.3e+00
—
1.0e+50
—
—
7.5e-01
—
—
cases:1.94%
controls:0.19%
—
—
cases:1.29%
controls:0.00%
—
—
—
—
cases:1.47%
controls:0.70%
—
9
9
455
4614
—
6
0
458
4623
—
—
6
29
403
4117
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 [2002330110]
—
—
2.3e+00
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
7
7
457
4616
—
—
—
—
Bacterial pneumonia, unspecified
J15.9 [45557621]
7.7e-01
2.3e+00
—
—
—
—
3.5e-01
cases:1.29%
controls:0.61%
cases:1.51%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.87%
6
28
458
4595
7
7
457
4616
—
—
—
—
5
36
404
4110
Infiltration anesthesia
WX110 [2001310767]
6.6e-02
7.7e-01
1.5e+00
—
8.8e-01
4.8e-01
3.2e-01
cases:16.16%
controls:15.29%
cases:11.64%
controls:5.75%
cases:2.59%
controls:0.58%
—
—
cases:2.38%
controls:1.00%
cases:8.67%
controls:5.56%
cases:21.27%
controls:16.38%
75
707
389
3916
54
266
410
4357
12
27
452
4596
—
11
46
452
4574
39
253
411
4296
87
679
322
3467
Otolaryngology
4 [38004449]
2.5e-01
8.1e-01
1.4e+00
1.0e+50
1.1e+00
3.3e-01
2.1e-01
cases:12.28%
controls:9.82%
cases:8.62%
controls:4.02%
cases:2.16%
controls:0.52%
cases:1.72%
controls:0.00%
cases:1.73%
controls:0.58%
cases:5.33%
controls:3.89%
cases:12.22%
controls:10.15%
57
454
407
4169
40
186
424
4437
10
24
454
4599
8
0
456
4623
8
27
455
4593
24
177
426
4372
50
421
359
3725
More than five and less than seven hours
ZXE30 [2001311411]
—
-1.0e+50
—
—
—
—
2.2e+00
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.24%
—
0
6
464
4617
—
—
—
—
9
10
400
4136
Basophils [#/volume] in Blood
26444-0 [3006315]
4.3e-02
1.1e+00
9.3e-01
—
1.0e+00
6.3e-01
5.0e-01
cases:9.27%
controls:8.91%
cases:14.87%
controls:5.52%
cases:3.02%
controls:1.21%
—
—
cases:2.38%
controls:0.89%
cases:9.78%
controls:5.45%
cases:19.32%
controls:12.66%
43
412
421
4211
69
255
395
4368
14
56
450
4567
—
11
41
452
4579
44
248
406
4301
79
525
330
3621
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.8e-02
1.1e+00
9.5e-01
—
1.0e+00
6.4e-01
4.9e-01
cases:9.27%
controls:8.87%
cases:14.87%
controls:5.52%
cases:3.02%
controls:1.19%
—
—
cases:2.38%
controls:0.89%
cases:9.78%
controls:5.41%
cases:19.07%
controls:12.59%
43
410
421
4213
69
255
395
4368
14
55
450
4568
—
11
41
452
4579
44
246
406
4303
78
522
331
3624
Counselling and guidance which enhance independent living
R2130 [2001310196]
4.0e-01
2.2e+00
—
—
—
8.8e-01
5.1e-01
cases:1.51%
controls:1.02%
cases:1.94%
controls:0.22%
—
—
—
—
—
—
cases:1.11%
controls:0.46%
cases:1.71%
controls:1.04%
7
47
457
4576
9
10
455
4613
—
—
—
5
21
445
4528
7
43
402
4103
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
9.1e-02
1.1e+00
9.3e-01
—
9.8e-01
6.3e-01
4.7e-01
cases:9.91%
controls:9.13%
cases:15.30%
controls:5.65%
cases:3.02%
controls:1.21%
—
—
cases:2.38%
controls:0.91%
cases:10.00%
controls:5.61%
cases:19.32%
controls:13.00%
46
422
418
4201
71
261
393
4362
14
56
450
4567
—
11
42
452
4578
45
255
405
4294
79
539
330
3607
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
4.2e-01
2.2e+00
—
—
—
—
—
cases:1.08%
controls:0.71%
cases:1.72%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
5
33
459
4590
8
9
456
4614
—
—
—
—
—
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
—
2.2e+00
—
—
—
—
8.9e-01
—
—
cases:1.72%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.51%
—
8
9
456
4614
—
—
—
—
5
21
404
4125
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
—
-1.0e+50
—
—
—
2.2e+00
1.4e-02
—
—
cases:0.00%
controls:0.43%
—
—
—
—
—
—
cases:1.33%
controls:0.15%
cases:1.22%
controls:1.21%
—
0
20
464
4603
—
—
—
6
7
444
4542
5
50
404
4096
Internal Medicine
11 [38004456]
1.1e-01
1.0e+00
1.1e+00
—
7.4e-01
4.4e-01
4.0e-01
cases:21.55%
controls:19.68%
cases:18.97%
controls:7.72%
cases:3.88%
controls:1.28%
—
—
cases:2.16%
controls:1.04%
cases:10.44%
controls:6.97%
cases:25.43%
controls:18.60%
100
910
364
3713
88
357
376
4266
18
59
446
4564
—
10
48
453
4572
47
317
403
4232
104
771
305
3375
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
—
2.2e+00
—
—
—
—
—
—
—
cases:1.29%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
6
7
458
4616
—
—
—
—
—
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
208G00000X [38004023]
-1.0e+50
2.2e+00
—
1.0e+50
—
—
1.1e+00
cases:0.00%
controls:0.26%
cases:1.29%
controls:0.15%
—
—
cases:5.39%
controls:0.00%
—
—
—
—
cases:1.47%
controls:0.48%
0
12
464
4611
6
7
458
4616
—
25
0
439
4623
—
—
6
20
403
4126
Pleural plaque with presence of asbestos
J92.0 [45567277]
2.2e+00
—
—
—
—
—
—
cases:1.29%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
458
4616
—
—
—
—
—
—
Essential (primary) hypertension
I10 [45591453]
-5.0e-02
7.1e-01
1.4e+00
—
1.0e+00
1.5e-01
8.3e-02
cases:14.22%
controls:14.84%
cases:13.15%
controls:6.94%
cases:4.09%
controls:1.00%
—
—
cases:2.81%
controls:1.04%
cases:9.11%
controls:7.94%
cases:23.23%
controls:21.78%
66
686
398
3937
61
321
403
4302
19
46
445
4577
—
13
48
450
4572
41
361
409
4188
95
903
314
3243
Malignant tumour
130 [2001600128]
7.0e-01
—
—
—
—
2.1e+00
1.3e+00
cases:1.29%
controls:0.65%
—
—
—
—
—
—
—
—
cases:1.78%
controls:0.22%
cases:1.96%
controls:0.55%
6
30
458
4593
—
—
—
—
8
10
442
4539
8
23
401
4123
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
1.0e-01
8.5e-01
1.2e+00
—
6.3e-01
3.9e-01
3.8e-01
cases:8.84%
controls:8.05%
cases:11.21%
controls:5.10%
cases:3.02%
controls:0.93%
—
—
cases:2.38%
controls:1.28%
cases:6.89%
controls:4.75%
cases:17.11%
controls:12.42%
41
372
423
4251
52
236
412
4387
14
43
450
4580
—
11
59
452
4561
31
216
419
4333
70
515
339
3631
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
—
—
—
—
1.0e+50
—
2.0e+00
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.00%
—
—
cases:2.20%
controls:0.29%
—
—
—
—
5
0
458
4620
—
9
12
400
4134
Intubation
WX704 [2001310820]
—
2.0e+00
—
1.0e+50
—
—
7.7e-01
—
—
cases:2.59%
controls:0.35%
—
—
cases:1.72%
controls:0.00%
—
—
—
—
cases:1.71%
controls:0.80%
—
12
16
452
4607
—
8
0
456
4623
—
—
7
33
402
4113
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
3.0e-01
2.0e-01
2.0e+00
—
—
4.6e-01
7.7e-02
cases:3.02%
controls:2.25%
cases:1.08%
controls:0.89%
cases:1.29%
controls:0.17%
—
—
—
—
cases:1.56%
controls:0.99%
cases:4.16%
controls:3.86%
14
104
450
4519
5
41
459
4582
6
8
458
4615
—
—
7
45
443
4504
17
160
392
3986
Rheumatology
66 [38004491]
3.2e-01
9.1e-01
—
—
—
1.1e+00
6.2e-01
cases:3.45%
controls:2.53%
cases:3.88%
controls:1.60%
—
—
—
—
—
—
cases:4.22%
controls:1.43%
cases:5.13%
controls:2.82%
16
117
448
4506
18
74
446
4549
—
—
—
19
65
431
4484
21
117
388
4029
zopiclone; oral
N05CF01 [21604654]
-1.5e-01
3.8e-01
7.5e-01
—
1.3e+00
6.9e-01
5.3e-01
cases:6.25%
controls:7.18%
cases:5.82%
controls:4.04%
cases:1.72%
controls:0.82%
—
—
cases:4.10%
controls:1.15%
cases:7.56%
controls:3.93%
cases:12.22%
controls:7.57%
29
332
435
4291
27
187
437
4436
8
38
456
4585
—
19
53
444
4567
34
179
416
4370
50
314
359
3832
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
—
2.0e+00
—
1.0e+50
—
1.4e+00
1.0e+00
—
—
cases:1.72%
controls:0.24%
—
—
cases:1.29%
controls:0.00%
—
—
cases:1.11%
controls:0.26%
cases:2.69%
controls:0.99%
—
8
11
456
4612
—
6
0
458
4623
—
5
12
445
4537
11
41
398
4105
moxifloxacin; oral, parenteral
J01MA14 [21603021]
—
2.0e+00
—
—
—
—
9.4e-01
—
—
cases:1.72%
controls:0.24%
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.77%
—
8
11
456
4612
—
—
—
—
8
32
401
4114
Fever, unspecified
R50.9 [45582716]
3.8e-02
2.0e+00
—
—
—
—
6.2e-01
cases:1.08%
controls:1.04%
cases:2.16%
controls:0.30%
—
—
—
—
—
—
—
—
cases:2.44%
controls:1.33%
5
48
459
4575
10
14
454
4609
—
—
—
—
10
55
399
4091
Neoplasm of uncertain or unknown behaviour: Kidney
D41.0 [45581311]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.24%
—
—
—
—
—
—
7
10
402
4136
Occupatioal Medicine
901 [44777713]
2.0e+00
—
—
—
—
—
—
cases:1.51%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
—
7
10
457
4613
—
—
—
—
—
—
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
5.8e-01
1.9e+00
—
1.0e+50
1.0e+50
1.7e+00
5.2e-01
cases:1.08%
controls:0.61%
cases:2.37%
controls:0.35%
—
—
cases:1.51%
controls:0.00%
cases:1.08%
controls:0.00%
cases:1.56%
controls:0.29%
cases:2.69%
controls:1.62%
5
28
459
4595
11
16
453
4607
—
7
0
457
4623
5
0
458
4620
7
13
443
4536
11
67
398
4079
Gas panel - Central venous blood
97535-9 [1616796]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.29%
—
—
—
—
—
—
8
12
401
4134
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
-1.0e-01
1.5e-01
1.9e+00
—
—
—
4.7e-01
cases:1.08%
controls:1.19%
cases:1.08%
controls:0.93%
cases:1.72%
controls:0.26%
—
—
—
—
—
—
cases:2.93%
controls:1.86%
5
55
459
4568
5
43
459
4580
8
12
456
4611
—
—
—
12
77
397
4069
Medical Oncology
90 [38004507]
-1.1e-02
4.6e-01
7.8e-01
—
9.5e-01
1.0e+00
8.7e-01
cases:3.23%
controls:3.27%
cases:3.88%
controls:2.49%
cases:1.72%
controls:0.80%
—
—
cases:2.81%
controls:1.10%
cases:6.44%
controls:2.42%
cases:9.29%
controls:4.10%
15
151
449
4472
18
115
446
4508
8
37
456
4586
—
13
51
450
4569
29
110
421
4439
38
170
371
3976
Metastasis to lung
OMOP4999962 [36770283]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.27%
—
—
—
—
—
—
7
11
402
4135
Secondary malignant neoplasm of lung
C78.0 [45537839]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.27%
—
—
—
—
—
—
7
11
402
4135
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
1.3e-01
1.4e-01
1.9e+00
—
—
1.8e-01
-9.9e-02
cases:4.96%
controls:4.39%
cases:2.37%
controls:2.08%
cases:1.94%
controls:0.30%
—
—
—
—
cases:2.44%
controls:2.04%
cases:6.36%
controls:6.97%
23
203
441
4420
11
96
453
4527
9
14
455
4609
—
—
11
93
439
4456
26
289
383
3857
Spirometry study
18759-1 [3000492]
5.2e-01
1.9e+00
—
—
—
—
7.2e-01
cases:2.80%
controls:1.69%
cases:2.59%
controls:0.41%
—
—
—
—
—
—
—
—
cases:3.18%
controls:1.57%
13
78
451
4545
12
19
452
4604
—
—
—
—
13
65
396
4081
Enzyme measurement
122444009 [4046263]
7.0e-01
1.9e+00
—
—
—
—
7.2e-01
cases:1.29%
controls:0.65%
cases:1.51%
controls:0.24%
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.84%
6
30
458
4593
7
11
457
4612
—
—
—
—
7
35
402
4111
Other chronic obstructive pulmonary disease
J44 [45543268]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.31%
—
—
—
—
—
—
8
13
401
4133
Other chest pain
R07.3 [45597166]
6.2e-01
—
—
—
—
1.8e+00
7.4e-01
cases:1.08%
controls:0.58%
—
—
—
—
—
—
—
—
cases:1.78%
controls:0.29%
cases:2.44%
controls:1.18%
5
27
459
4596
—
—
—
—
8
13
442
4536
10
49
399
4097
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
—
1.8e+00
—
1.0e+50
1.0e+50
1.6e+00
7.8e-01
—
—
cases:1.72%
controls:0.28%
—
—
cases:1.29%
controls:0.00%
cases:1.08%
controls:0.00%
cases:1.33%
controls:0.29%
cases:2.44%
controls:1.13%
—
8
13
456
4610
—
6
0
458
4623
5
0
458
4620
6
13
444
4536
10
47
399
4099
codeine and paracetamol
N02AJ06 [1123647]
2.9e-01
4.6e-01
9.8e-01
—
1.8e+00
1.5e-01
4.4e-01
cases:15.09%
controls:11.75%
cases:6.90%
controls:4.46%
cases:1.94%
controls:0.74%
—
—
cases:4.10%
controls:0.69%
cases:5.33%
controls:4.62%
cases:17.11%
controls:11.70%
70
543
394
4080
32
206
432
4417
9
34
455
4589
—
19
32
444
4588
24
210
426
4339
70
485
339
3661
Gas panel - Arterial blood
24336-0 [3019060]
5.1e-01
1.8e+00
—
1.0e+50
—
1.3e+00
1.2e-01
cases:1.08%
controls:0.65%
cases:1.94%
controls:0.32%
—
—
cases:1.51%
controls:0.00%
—
—
cases:1.33%
controls:0.35%
cases:1.47%
controls:1.30%
5
30
459
4593
9
15
455
4608
—
7
0
457
4623
—
6
16
444
4533
6
54
403
4092
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-5.4e-02
1.8e+00
—
—
—
—
5.0e-01
cases:2.16%
controls:2.27%
cases:5.39%
controls:0.93%
—
—
—
—
—
—
—
—
cases:4.40%
controls:2.73%
10
105
454
4518
25
43
439
4580
—
—
—
—
18
113
391
4033
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
3.0e-01
1.2e+00
1.4e+00
—
1.2e+00
6.1e-01
6.4e-01
cases:4.31%
controls:3.22%
cases:6.25%
controls:2.03%
cases:1.51%
controls:0.37%
—
—
cases:1.30%
controls:0.41%
cases:4.22%
controls:2.33%
cases:10.02%
controls:5.57%
20
149
444
4474
29
94
435
4529
7
17
457
4606
—
6
19
457
4601
19
106
431
4443
41
231
368
3915
Teaching
WZC30 [2001310891]
—
1.8e+00
—
—
—
1.1e+00
6.5e-01
—
—
cases:4.53%
controls:0.80%
—
—
—
—
—
—
cases:2.00%
controls:0.70%
cases:4.16%
controls:2.22%
—
21
37
443
4586
—
—
—
9
32
441
4517
17
92
392
4054
salmeterol; inhalant
R03AC12 [21603266]
1.2e+00
—
—
—
—
—
1.7e+00
cases:1.29%
controls:0.39%
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.36%
6
18
458
4605
—
—
—
—
—
8
15
401
4131
Intravenous
ZX120 [2001311495]
3.2e-01
1.1e+00
—
—
—
1.7e+00
5.3e-01
cases:1.51%
controls:1.10%
cases:1.29%
controls:0.45%
—
—
—
—
—
—
cases:2.22%
controls:0.42%
cases:1.47%
controls:0.87%
7
51
457
4572
6
21
458
4602
—
—
—
10
19
440
4530
6
36
403
4110
Predominantly allergic asthma
J45.0 [45557624]
2.0e-01
1.7e+00
—
—
—
8.9e-01
8.4e-01
cases:1.08%
controls:0.89%
cases:1.94%
controls:0.37%
—
—
—
—
—
—
cases:1.33%
controls:0.55%
cases:2.20%
controls:0.96%
5
41
459
4582
9
17
455
4606
—
—
—
6
25
444
4524
9
40
400
4106
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
—
1.7e+00
—
—
—
1.3e+00
3.1e-01
—
—
cases:2.37%
controls:0.45%
—
—
—
—
—
—
cases:1.33%
controls:0.35%
cases:2.93%
controls:2.17%
—
11
21
453
4602
—
—
—
6
16
444
4533
12
90
397
4056
Respiratory and circulatory monitoring
WX700 [2001310817]
6.7e-02
1.6e+00
—
1.0e+50
—
—
6.2e-01
cases:1.94%
controls:1.82%
cases:3.45%
controls:0.69%
—
—
cases:1.51%
controls:0.00%
—
—
—
—
cases:2.69%
controls:1.47%
9
84
455
4539
16
32
448
4591
—
7
0
457
4623
—
—
11
61
398
4085
methotrexate; oral, parenteral
L04AX03 [21603929]
3.5e-01
6.9e-01
1.3e+00
—
1.6e+00
8.5e-01
6.5e-01
cases:2.59%
controls:1.84%
cases:2.59%
controls:1.32%
cases:1.72%
controls:0.50%
—
—
cases:1.94%
controls:0.39%
cases:2.89%
controls:1.25%
cases:3.18%
controls:1.69%
12
85
452
4538
12
61
452
4562
8
23
456
4600
—
9
18
454
4602
13
57
437
4492
13
70
396
4076
methotrexate
L01BA01 [21601423]
3.5e-01
6.9e-01
1.3e+00
—
1.6e+00
8.5e-01
6.5e-01
cases:2.59%
controls:1.84%
cases:2.59%
controls:1.32%
cases:1.72%
controls:0.50%
—
—
cases:1.94%
controls:0.39%
cases:2.89%
controls:1.25%
cases:3.18%
controls:1.69%
12
85
452
4538
12
61
452
4562
8
23
456
4600
—
9
18
454
4602
13
57
437
4492
13
70
396
4076
Atrial fibrillation and flutter
I48 [45596206]
-3.8e-03
5.3e-01
1.2e+00
1.0e+50
1.6e+00
4.9e-02
1.8e-01
cases:4.31%
controls:4.33%
cases:3.66%
controls:2.18%
cases:1.72%
controls:0.52%
cases:1.51%
controls:0.00%
cases:1.73%
controls:0.35%
cases:2.44%
controls:2.33%
cases:7.33%
controls:6.22%
20
200
444
4423
17
101
447
4522
8
24
456
4599
7
0
457
4623
8
16
455
4604
11
106
439
4443
30
258
379
3888
Oral Surgery
19 [38004464]
8.9e-01
—
—
—
—
—
1.6e+00
cases:1.72%
controls:0.71%
—
—
—
—
—
—
—
—
—
—
cases:2.69%
controls:0.55%
8
33
456
4590
—
—
—
—
—
11
23
398
4123
General anesthesia, balanced
WX408 [2001310808]
6.8e-02
1.6e+00
—
1.0e+50
1.0e+50
6.3e-01
8.6e-01
cases:3.88%
controls:3.63%
cases:4.31%
controls:0.91%
—
—
cases:7.76%
controls:0.00%
cases:1.51%
controls:0.00%
cases:1.11%
controls:0.59%
cases:4.16%
controls:1.81%
18
168
446
4455
20
42
444
4581
—
36
0
428
4623
7
0
456
4620
5
27
445
4522
17
75
392
4071
Acute bronchitis, unspecified
J20.9 [45562445]
-1.5e-01
1.6e+00
—
—
—
5.3e-01
5.6e-01
cases:1.29%
controls:1.49%
cases:2.59%
controls:0.54%
—
—
—
—
—
—
cases:1.33%
controls:0.79%
cases:4.16%
controls:2.41%
6
69
458
4554
12
25
452
4598
—
—
—
6
36
444
4513
17
100
392
4046
ABO and Rh group [Type] in Blood
882-1 [3003694]
-7.1e-02
1.6e+00
—
—
—
4.1e-01
-1.4e-01
cases:3.23%
controls:3.46%
cases:5.82%
controls:1.25%
—
—
—
—
—
—
cases:1.78%
controls:1.19%
cases:3.42%
controls:3.93%
15
160
449
4463
27
58
437
4565
—
—
—
8
54
442
4495
14
163
395
3983
Eosinophils [#/volume] in Blood
26449-9 [3013115]
3.6e-02
1.1e+00
8.0e-01
—
8.6e-01
5.7e-01
4.8e-01
cases:9.70%
controls:9.39%
cases:15.30%
controls:5.80%
cases:2.80%
controls:1.28%
—
—
cases:2.38%
controls:1.02%
cases:9.78%
controls:5.76%
cases:19.80%
controls:13.29%
45
434
419
4189
71
268
393
4355
13
59
451
4564
—
11
47
452
4573
44
262
406
4287
81
551
328
3595
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.48%
—
—
—
—
—
—
9
20
400
4126
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
—
1.5e+00
—
—
—
1.3e+00
2.9e-01
—
—
cases:2.16%
controls:0.48%
—
—
—
—
—
—
cases:1.33%
controls:0.37%
cases:3.18%
controls:2.39%
—
10
22
454
4601
—
—
—
6
17
444
4532
13
99
396
4047
pH of Serum or Plasma
2753-2 [3018418]
-7.1e-02
8.2e-01
9.7e-01
—
—
6.4e-01
6.7e-01
cases:3.88%
controls:4.15%
cases:5.60%
controls:2.55%
cases:1.08%
controls:0.41%
—
—
—
—
cases:4.22%
controls:2.26%
cases:11.74%
controls:6.34%
18
192
446
4431
26
118
438
4505
5
19
459
4604
—
—
19
103
431
4446
48
263
361
3883
Urology
34 [38004474]
3.1e-01
6.9e-01
1.5e+00
—
8.9e-01
7.7e-01
5.2e-01
cases:8.19%
controls:6.12%
cases:6.68%
controls:3.48%
cases:1.94%
controls:0.45%
—
—
cases:1.51%
controls:0.63%
cases:6.89%
controls:3.30%
cases:12.47%
controls:7.81%
38
283
426
4340
31
161
433
4462
9
21
455
4602
—
7
29
456
4591
31
150
419
4399
51
324
358
3822
More than one and less than three hours
ZXE10 [2001311401]
1.8e-01
1.4e+00
—
—
—
9.2e-01
5.0e-01
cases:5.39%
controls:4.54%
cases:4.09%
controls:1.00%
—
—
—
—
—
—
cases:2.22%
controls:0.90%
cases:5.62%
controls:3.50%
25
210
439
4413
19
46
445
4577
—
—
—
10
41
440
4508
23
145
386
4001
Microorganisms panel - Urine sediment
58435-9 [40761536]
1.6e-01
9.2e-01
—
—
—
7.5e-01
1.4e+00
cases:1.29%
controls:1.10%
cases:1.51%
controls:0.61%
—
—
—
—
—
—
cases:1.11%
controls:0.53%
cases:4.89%
controls:1.21%
6
51
458
4572
7
28
457
4595
—
—
—
5
24
445
4525
20
50
389
4096
Paraesthesia of skin
R20.2 [45568120]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.44%
controls:0.60%
—
—
—
—
—
—
10
25
399
4121
prednisolone; oral, parenteral
H02AB06 [21602734]
4.6e-01
8.1e-01
—
—
1.3e+00
5.3e-01
5.9e-01
cases:13.58%
controls:9.02%
cases:8.19%
controls:3.81%
—
—
—
—
cases:2.16%
controls:0.61%
cases:6.67%
controls:4.04%
cases:15.89%
controls:9.48%
63
417
401
4206
38
176
426
4447
—
—
10
28
453
4592
30
184
420
4365
65
393
344
3753
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
2.1e-01
1.4e+00
—
—
—
8.5e-01
2.3e-01
cases:3.45%
controls:2.81%
cases:2.59%
controls:0.65%
—
—
—
—
—
—
cases:1.78%
controls:0.77%
cases:4.65%
controls:3.74%
16
130
448
4493
12
30
452
4593
—
—
—
8
35
442
4514
19
155
390
3991
prednisolone
A07EA01 [21600653]
4.7e-01
8.1e-01
—
—
1.3e+00
5.3e-01
5.8e-01
cases:13.79%
controls:9.09%
cases:8.19%
controls:3.81%
—
—
—
—
cases:2.16%
controls:0.61%
cases:6.67%
controls:4.04%
cases:15.89%
controls:9.53%
64
420
400
4203
38
176
426
4447
—
—
10
28
453
4592
30
184
420
4365
65
395
344
3751
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
-3.9e-01
1.4e+00
—
—
—
1.4e+00
-4.2e-01
cases:1.29%
controls:1.90%
cases:2.59%
controls:0.67%
—
—
—
—
—
—
cases:1.56%
controls:0.40%
cases:1.71%
controls:2.58%
6
88
458
4535
12
31
452
4592
—
—
—
7
18
443
4531
7
107
402
4039
erdosteine; oral
R05CB15 [21603394]
2.2e-01
1.3e+00
-1.0e+50
—
—
8.9e-01
-3.3e-01
cases:2.80%
controls:2.27%
cases:2.59%
controls:0.69%
cases:0.00%
controls:0.13%
—
—
—
—
cases:2.22%
controls:0.92%
cases:2.44%
controls:3.35%
13
105
451
4518
12
32
452
4591
0
6
464
4617
—
—
10
42
440
4507
10
139
399
4007
Right side
ZXA00 [2001311346]
3.1e-01
1.3e+00
—
1.0e+50
—
6.7e-01
5.2e-01
cases:4.31%
controls:3.20%
cases:3.23%
controls:0.89%
—
—
cases:3.45%
controls:0.00%
—
—
cases:1.11%
controls:0.57%
cases:4.16%
controls:2.51%
20
148
444
4475
15
41
449
4582
—
16
0
448
4623
—
5
26
445
4523
17
104
392
4042
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
—
1.3e+00
—
—
—
1.1e+00
4.7e-01
—
—
cases:2.59%
controls:0.71%
—
—
—
—
—
—
cases:1.78%
controls:0.57%
cases:4.65%
controls:2.97%
—
12
33
452
4590
—
—
—
8
26
442
4523
19
123
390
4023
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
8.0e-02
7.8e-01
—
—
-1.0e+50
1.3e+00
4.3e-01
cases:3.02%
controls:2.79%
cases:2.37%
controls:1.10%
—
—
—
—
cases:0.00%
controls:0.15%
cases:2.67%
controls:0.75%
cases:3.91%
controls:2.58%
14
129
450
4494
11
51
453
4572
—
—
0
7
463
4613
12
34
438
4515
16
107
393
4039
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-3.6e-02
5.5e-01
7.3e-01
—
4.0e-01
2.3e-01
8.8e-02
cases:26.51%
controls:27.21%
cases:32.11%
controls:21.46%
cases:7.33%
controls:3.66%
—
—
cases:5.83%
controls:3.98%
cases:26.44%
controls:22.16%
cases:43.03%
controls:40.88%
123
1258
341
3365
149
992
315
3631
34
169
430
4454
—
27
184
436
4436
119
1008
331
3541
176
1695
233
2451
Other and unspecified abdominal pain
R10.4 [45568113]
4.9e-01
1.2e+00
—
—
—
4.4e-01
6.3e-01
cases:5.60%
controls:3.50%
cases:3.23%
controls:0.95%
—
—
—
—
—
—
cases:1.56%
controls:1.01%
cases:8.31%
controls:4.61%
26
162
438
4461
15
44
449
4579
—
—
—
7
46
443
4503
34
191
375
3955
Cough
R05 [2002000886]
7.6e-02
1.2e+00
-1.0e+50
—
—
1.2e-01
3.9e-01
cases:2.59%
controls:2.40%
cases:2.80%
controls:0.82%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.11%
controls:0.99%
cases:4.65%
controls:3.21%
12
111
452
4512
13
38
451
4585
0
5
464
4618
—
—
5
45
445
4504
19
133
390
4013
antibiotics in combination with corticosteroids
D01AA20 [21601918]
6.6e-01
—
—
—
—
1.0e+00
1.2e+00
cases:2.16%
controls:1.12%
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.48%
cases:3.91%
controls:1.16%
10
52
454
4571
—
—
—
—
6
22
444
4527
16
48
393
4098
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
—
5.1e-01
—
—
—
2.9e-01
1.2e+00
—
—
cases:1.08%
controls:0.65%
—
—
—
—
—
—
cases:1.11%
controls:0.84%
cases:6.11%
controls:1.86%
—
5
30
459
4593
—
—
—
5
38
445
4511
25
77
384
4069
Cardiology
6 [38004451]
-1.3e-01
5.6e-01
1.2e+00
—
—
1.6e-01
1.7e-01
cases:8.19%
controls:9.19%
cases:8.19%
controls:4.85%
cases:2.59%
controls:0.78%
—
—
—
—
cases:4.89%
controls:4.18%
cases:12.71%
controls:10.90%
38
425
426
4198
38
224
426
4399
12
36
452
4587
—
—
22
190
428
4359
52
452
357
3694
Blasts/Leukocytes in Blood
26446-5 [3025159]
—
4.2e-01
—
—
—
3.0e-01
1.2e+00
—
—
cases:1.08%
controls:0.71%
—
—
—
—
—
—
cases:1.33%
controls:0.99%
cases:6.36%
controls:1.98%
—
5
33
459
4590
—
—
—
6
45
444
4504
26
82
383
4064
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
3.7e-01
1.2e+00
—
—
—
7.0e-01
1.5e-01
cases:4.09%
controls:2.86%
cases:4.09%
controls:1.25%
—
—
—
—
—
—
cases:2.44%
controls:1.23%
cases:4.65%
controls:4.03%
19
132
445
4491
19
58
445
4565
—
—
—
11
56
439
4493
19
167
390
3979
naproxen; oral, rectal
M01AE02 [21603968]
4.8e-01
1.2e+00
—
—
1.5e+00
2.4e-01
9.4e-02
cases:11.64%
controls:7.53%
cases:5.82%
controls:1.82%
—
—
—
—
cases:1.51%
controls:0.35%
cases:3.33%
controls:2.64%
cases:7.58%
controls:6.95%
54
348
410
4275
27
84
437
4539
—
—
7
16
456
4604
15
120
435
4429
31
288
378
3858
naproxcinod
M01AE18 [40254094]
4.8e-01
1.2e+00
—
—
1.5e+00
2.4e-01
9.4e-02
cases:11.64%
controls:7.53%
cases:5.82%
controls:1.82%
—
—
—
—
cases:1.51%
controls:0.35%
cases:3.33%
controls:2.64%
cases:7.58%
controls:6.95%
54
348
410
4275
27
84
437
4539
—
—
7
16
456
4604
15
120
435
4429
31
288
378
3858
Emergency Room and Inpatient Visit
ERIP [262]
-1.1e-02
1.2e+00
1.9e+00
—
1.6e+00
1.8e-01
2.9e-01
cases:3.02%
controls:3.05%
cases:5.82%
controls:1.86%
cases:1.29%
controls:0.19%
—
—
cases:1.08%
controls:0.22%
cases:2.44%
controls:2.04%
cases:9.29%
controls:7.09%
14
141
450
4482
27
86
437
4537
6
9
458
4614
—
5
10
458
4610
11
93
439
4456
38
294
371
3852
Chest pain, unspecified
R07.4 [45558450]
3.7e-01
1.2e+00
—
—
—
—
2.9e-01
cases:4.74%
controls:3.33%
cases:3.66%
controls:1.17%
—
—
—
—
—
—
—
—
cases:5.87%
controls:4.44%
22
154
442
4469
17
54
447
4569
—
—
—
—
24
184
385
3962
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
—
3.3e-01
—
—
—
1.4e-01
1.2e+00
—
—
cases:1.08%
controls:0.78%
—
—
—
—
—
—
cases:1.11%
controls:0.97%
cases:6.11%
controls:2.00%
—
5
36
459
4587
—
—
—
5
44
445
4505
25
83
384
4063
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
—
3.6e-01
—
—
—
1.4e-01
1.2e+00
—
—
cases:1.08%
controls:0.76%
—
—
—
—
—
—
cases:1.11%
controls:0.97%
cases:5.87%
controls:1.93%
—
5
35
459
4588
—
—
—
5
44
445
4505
24
80
385
4066
Other specified special examinations
Z01.8 [45581003]
3.3e-01
1.1e+00
—
—
—
9.1e-01
2.4e-01
cases:3.45%
controls:2.51%
cases:2.80%
controls:0.93%
—
—
—
—
—
—
cases:2.00%
controls:0.81%
cases:3.67%
controls:2.92%
16
116
448
4507
13
43
451
4580
—
—
—
9
37
441
4512
15
121
394
4025
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
3.6e-01
1.1e+00
—
—
—
9.8e-01
1.1e+00
cases:1.29%
controls:0.91%
cases:1.94%
controls:0.63%
—
—
—
—
—
—
cases:1.33%
controls:0.51%
cases:4.16%
controls:1.40%
6
42
458
4581
9
29
455
4594
—
—
—
6
23
444
4526
17
58
392
4088
Endocrinology
46 [38004485]
-1.6e-01
1.1e-02
1.4e+00
—
—
1.0e+00
5.1e-01
cases:2.16%
controls:2.53%
cases:1.51%
controls:1.49%
cases:1.08%
controls:0.28%
—
—
—
—
cases:3.11%
controls:1.12%
cases:4.40%
controls:2.70%
10
117
454
4506
7
69
457
4554
5
13
459
4610
—
—
14
51
436
4498
18
112
391
4034
Left side
ZXA05 [2001311347]
-2.7e-01
1.1e+00
—
1.0e+50
—
7.1e-01
1.0e+00
cases:2.37%
controls:3.09%
cases:2.16%
controls:0.71%
—
—
cases:2.37%
controls:0.00%
—
—
cases:1.33%
controls:0.66%
cases:6.11%
controls:2.29%
11
143
453
4480
10
33
454
4590
—
11
0
453
4623
—
6
30
444
4519
25
95
384
4051
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
2.3e-01
1.0e+00
—
—
—
2.1e-01
5.4e-01
cases:5.17%
controls:4.15%
cases:5.17%
controls:1.95%
—
—
—
—
—
—
cases:2.67%
controls:2.18%
cases:10.76%
controls:6.58%
24
192
440
4431
24
90
440
4533
—
—
—
12
99
438
4450
44
273
365
3873
methylprednisolone; oral, parenteral
H02AB04 [21602732]
2.9e-01
—
-1.0e+50
—
—
—
1.0e+00
cases:2.16%
controls:1.62%
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:3.67%
controls:1.37%
10
75
454
4548
—
0
5
464
4618
—
—
—
15
57
394
4089
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-7.3e-02
1.0e+00
8.6e-01
-1.0e+50
2.2e-01
4.6e-01
3.3e-01
cases:9.70%
controls:10.36%
cases:16.59%
controls:6.84%
cases:3.88%
controls:1.69%
cases:0.00%
controls:0.11%
cases:1.94%
controls:1.56%
cases:10.00%
controls:6.57%
cases:18.83%
controls:14.25%
45
479
419
4144
77
316
387
4307
18
78
446
4545
0
5
464
4618
9
72
454
4548
45
299
405
4250
77
591
332
3555
Recording of ECG
SPAT1097 [2001700198]
5.0e-01
—
—
—
—
6.0e-01
9.6e-01
cases:2.59%
controls:1.58%
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.62%
cases:4.16%
controls:1.64%
12
73
452
4550
—
—
—
—
5
28
445
4521
17
68
392
4078
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
-4.4e-02
9.5e-01
—
—
—
2.5e-01
2.6e-01
cases:3.23%
controls:3.37%
cases:4.31%
controls:1.71%
—
—
—
—
—
—
cases:2.67%
controls:2.09%
cases:8.80%
controls:6.90%
15
156
449
4467
20
79
444
4544
—
—
—
12
95
438
4454
36
286
373
3860
fluticasone; nasal
R01AD08 [21605050]
3.4e-01
9.5e-01
—
—
—
5.1e-01
3.6e-01
cases:10.13%
controls:7.44%
cases:7.76%
controls:3.16%
—
—
—
—
—
—
cases:4.89%
controls:2.99%
cases:9.78%
controls:7.02%
47
344
417
4279
36
146
428
4477
—
—
—
22
136
428
4413
40
291
369
3855
fluticasone furoate; nasal
R01AD12 [21605053]
3.4e-01
9.5e-01
—
—
—
5.1e-01
3.6e-01
cases:10.13%
controls:7.44%
cases:7.76%
controls:3.16%
—
—
—
—
—
—
cases:4.89%
controls:2.99%
cases:9.78%
controls:7.02%
47
344
417
4279
36
146
428
4477
—
—
—
22
136
428
4413
40
291
369
3855
amoxicillin; oral, parenteral
J01CA04 [21602823]
9.5e-02
9.2e-01
1.1e+00
—
—
4.6e-01
1.5e-01
cases:18.75%
controls:17.35%
cases:11.85%
controls:5.08%
cases:1.29%
controls:0.43%
—
—
—
—
cases:8.22%
controls:5.34%
cases:20.05%
controls:17.82%
87
802
377
3821
55
235
409
4388
6
20
458
4603
—
—
37
243
413
4306
82
739
327
3407
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
2.2e-01
9.1e-01
—
—
—
6.3e-01
3.5e-01
cases:8.19%
controls:6.68%
cases:4.31%
controls:1.77%
—
—
—
—
—
—
cases:3.33%
controls:1.80%
cases:9.78%
controls:7.07%
38
309
426
4314
20
82
444
4541
—
—
—
15
82
435
4467
40
293
369
3853
Other primary gonarthrosis
M17.1 [45596493]
-2.0e-01
3.8e-01
-1.0e+50
—
—
5.5e-01
9.1e-01
cases:2.16%
controls:2.62%
cases:1.51%
controls:1.04%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.78%
controls:1.03%
cases:6.85%
controls:2.87%
10
121
454
4502
7
48
457
4575
0
5
464
4618
—
—
8
47
442
4502
28
119
381
4027
doxycycline; oral, parenteral
J01AA02 [21602800]
1.6e-01
9.1e-01
—
—
—
5.9e-01
4.1e-01
cases:18.97%
controls:16.63%
cases:11.42%
controls:4.95%
—
—
—
—
—
—
cases:7.56%
controls:4.35%
cases:20.54%
controls:14.64%
88
769
376
3854
53
229
411
4394
—
—
—
34
198
416
4351
84
607
325
3539
omeprazole; oral, parenteral
A02BC01 [21600096]
-4.8e-02
4.2e-01
—
—
—
5.1e-01
8.5e-01
cases:3.45%
controls:3.61%
cases:2.59%
controls:1.71%
—
—
—
—
—
—
cases:2.89%
controls:1.76%
cases:7.58%
controls:3.40%
16
167
448
4456
12
79
452
4544
—
—
—
13
80
437
4469
31
141
378
4005
Telephone prescription or other care instructions
WZB00 [2001310884]
3.1e-01
1.3e-02
—
—
—
7.9e-01
8.4e-01
cases:5.17%
controls:3.83%
cases:1.29%
controls:1.28%
—
—
—
—
—
—
cases:1.78%
controls:0.81%
cases:6.36%
controls:2.85%
24
177
440
4446
6
59
458
4564
—
—
—
8
37
442
4512
26
118
383
4028
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
1.6e-01
7.9e-01
1.4e+00
—
1.2e+00
4.0e-01
3.7e-01
cases:6.90%
controls:5.95%
cases:6.03%
controls:2.83%
cases:1.72%
controls:0.41%
—
—
cases:1.08%
controls:0.32%
cases:4.22%
controls:2.86%
cases:12.47%
controls:8.95%
32
275
432
4348
28
131
436
4492
8
19
456
4604
—
5
15
458
4605
19
130
431
4419
51
371
358
3775
Coloscopy
UJF32 [2001305029]
9.7e-02
6.1e-01
—
—
-1.0e+50
7.2e-01
7.2e-01
cases:3.23%
controls:2.94%
cases:1.94%
controls:1.06%
—
—
—
—
cases:0.00%
controls:0.13%
cases:2.22%
controls:1.10%
cases:6.85%
controls:3.45%
15
136
449
4487
9
49
455
4574
—
—
0
6
463
4614
10
50
440
4499
28
143
381
4003
Sampling
SPAT1263 [2001700364]
2.3e-01
3.1e-01
8.0e-01
—
—
3.3e-01
6.9e-01
cases:7.54%
controls:6.08%
cases:3.66%
controls:2.73%
cases:1.29%
controls:0.58%
—
—
—
—
cases:3.78%
controls:2.75%
cases:12.22%
controls:6.54%
35
281
429
4342
17
126
447
4497
6
27
458
4596
—
—
17
125
433
4424
50
271
359
3875
metronidazole; oral, rectal
P01AB01 [21604857]
-1.2e-02
4.7e-01
-1.0e+50
—
—
-5.9e-02
6.6e-01
cases:5.82%
controls:5.88%
cases:2.37%
controls:1.49%
cases:0.00%
controls:0.15%
—
—
—
—
cases:1.56%
controls:1.65%
cases:9.78%
controls:5.33%
27
272
437
4351
11
69
453
4554
0
7
464
4616
—
—
7
75
443
4474
40
221
369
3925
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
3.1e-01
6.3e-01
—
—
6.3e-01
5.8e-02
2.9e-01
cases:8.41%
controls:6.29%
cases:8.19%
controls:4.54%
—
—
—
—
cases:1.30%
controls:0.69%
cases:5.11%
controls:4.84%
cases:16.14%
controls:12.64%
39
291
425
4332
38
210
426
4413
—
—
6
32
457
4588
23
220
427
4329
66
524
343
3622
pseudoephedrine, combinations; oral
R01BA52 [21603213]
1.3e-01
3.1e-01
—
—
—
2.7e-01
5.7e-01
cases:10.13%
controls:9.02%
cases:3.66%
controls:2.70%
—
—
—
—
—
—
cases:3.78%
controls:2.92%
cases:13.20%
controls:7.94%
47
417
417
4206
17
125
447
4498
—
—
—
17
133
433
4416
54
329
355
3817
Anogenital (venereal) warts
A63.0 [45585929]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
0
8
464
4615
—
—
—
—
—
0
5
409
4141
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
6
464
4617
—
—
—
—
—
tenoxicam; oral, parenteral, rectal
M01AC02 [21603962]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
0
10
464
4613
—
—
—
—
0
7
450
4542
—
Amputation of toe
NHQ40 [2001308365]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
464
4618
—
—
—
—
—
—
Other health check-up
SPAT1370 [2001700471]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
0
15
464
4608
0
6
464
4617
—
—
—
—
—
allopurinol; oral, parenteral
M04AA01 [21604131]
1.2e-01
-1.5e-02
—
—
—
3.5e-01
7.4e-02
cases:2.80%
controls:2.49%
cases:1.94%
controls:1.97%
—
—
—
—
—
—
cases:2.89%
controls:2.04%
cases:3.91%
controls:3.64%
13
115
451
4508
9
91
455
4532
—
—
—
13
93
437
4456
16
151
393
3995
Sleep disorder, unspecified
G47.9 [45595948]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.43%
0
9
464
4614
—
—
—
—
—
0
18
409
4128
Percutaneous transluminal coronary angioplasty (PTCA), balloon only
FN2AA [2001303088]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
7
409
4139
Oral health check
SAB03 [2001310281]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
464
4618
—
—
—
—
—
—
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
—
—
—
—
—
-1.0e+50
1.3e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
cases:2.20%
controls:1.93%
—
—
—
—
—
0
21
450
4528
9
80
400
4066
formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
0
6
464
4617
—
—
—
—
0
11
450
4538
—
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
5.1e-01
—
—
—
—
1.4e+00
7.1e-01
cases:1.29%
controls:0.78%
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.29%
cases:2.93%
controls:1.47%
6
36
458
4587
—
—
—
—
5
13
445
4536
12
61
397
4085
ECG with 12 standard connections
XF400 [2001303368]
2.6e-02
1.3e+00
—
—
—
—
—
cases:1.51%
controls:1.47%
cases:1.72%
controls:0.48%
—
—
—
—
—
—
—
—
—
—
7
68
457
4555
8
22
456
4601
—
—
—
—
—
Sick sinus syndrome
I49.5 [45562354]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
12
464
4611
—
—
—
—
—
Thrombendarterectomy of internal carotid artery
PAF14 [2001308743]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
0
9
409
4137
Mixed conductive and sensorineural hearing loss, bilateral
H90.6 [45601013]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
464
4618
—
—
—
—
—
—
ketoconazole; oral
J02AB02 [21603078]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
464
4618
—
—
—
—
—
—
Cardiovascular sympt/complt other
K29 [2002000556]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
0
19
464
4604
—
—
—
—
0
7
450
4542
—
Chronic maxillary sinusitis
J32.0 [45586667]
5.5e-01
—
—
—
—
—
—
cases:1.08%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
—
—
5
29
459
4594
—
—
—
—
—
—
Major custom moulded orthopaedic cast, knee or lower leg
TNG34 [2001308229]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
464
4616
—
—
—
—
—
—
Need for immunization against other specified single viral diseases
Z25.8 [45547296]
—
—
—
—
—
-6.7e-02
-6.3e-02
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:1.19%
cases:2.20%
controls:2.34%
—
—
—
—
—
5
54
445
4495
9
97
400
4049
Acute subendocardial infarction stenosed coronary artery
I21.41 [2000502433]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.39%
—
—
—
—
—
0
7
450
4542
0
16
409
4130
Neurological sympt/complt other
N29 [2002000734]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
464
4613
—
—
—
—
—
—
Fear of hypertension
K25 [2002000553]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
464
4612
—
—
—
—
—
—
Photography of skin or subcutaneous tissue in lower extremities, unspecified
QD9S1 [2001310014]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
464
4617
—
—
—
—
—
—
Dermatitis, unspecified
L30.9 [45572271]
4.3e-01
—
—
—
—
7.1e-01
7.6e-02
cases:2.37%
controls:1.56%
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.66%
cases:2.93%
controls:2.73%
11
72
453
4551
—
—
—
—
6
30
444
4519
12
113
397
4033
Unspecified haematuria
R31 [45553726]
4.3e-01
1.0e+00
—
—
—
—
1.9e-01
cases:1.29%
controls:0.84%
cases:1.08%
controls:0.39%
—
—
—
—
—
—
—
—
cases:1.22%
controls:1.01%
6
39
458
4584
5
18
459
4605
—
—
—
—
5
42
404
4104
opium derivatives and expectorants
R05FA02 [21603439]
7.6e-02
—
—
—
-1.0e+50
8.8e-01
8.4e-01
cases:1.72%
controls:1.60%
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:1.11%
controls:0.46%
cases:2.69%
controls:1.18%
8
74
456
4549
—
—
—
0
5
463
4615
5
21
445
4528
11
49
398
4097
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
0
5
464
4618
—
—
—
—
—
Intracerebral haemorrhage, unspecified
I61.9 [45576882]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
0
6
409
4140
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
-1.4e-01
-1.2e-01
-1.0e-01
—
—
-2.1e-01
-3.8e-02
cases:21.55%
controls:24.05%
cases:13.79%
controls:15.34%
cases:1.51%
controls:1.67%
—
—
—
—
cases:13.33%
controls:15.94%
cases:36.19%
controls:37.07%
100
1112
364
3511
64
709
400
3914
7
77
457
4546
—
—
60
725
390
3824
148
1537
261
2609
Custom moulded cast, unspecified region
TNX33 [2001308564]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.43%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:0.00%
controls:0.39%
0
20
464
4603
—
—
—
—
0
5
450
4544
0
16
409
4130
Protein electrophoresis panel - 24 hour Urine
81231-3 [21494890]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
0
5
409
4141
Counselling related to known health issue
SPAT1310 [2001700411]
6.3e-02
3.2e-01
-1.0e+50
—
—
1.3e-01
2.6e-01
cases:4.53%
controls:4.26%
cases:2.16%
controls:1.58%
cases:0.00%
controls:0.17%
—
—
—
—
cases:2.22%
controls:1.96%
cases:6.36%
controls:4.99%
21
197
443
4426
10
73
454
4550
0
8
464
4615
—
—
10
89
440
4460
26
207
383
3939
Other and unspecified abnormalities of gait and mobility
R26.8 [45597174]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
0
7
464
4616
—
—
—
—
—
0
8
409
4138
Cutaneous abscess, furuncle and carbuncle of trunk
L02.2 [45586751]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
0
5
464
4618
—
—
—
—
—
olopatadine
R01AC08 [21605040]
—
—
—
—
—
—
4.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.77%
—
—
—
—
—
—
5
32
404
4114
Insertion of urinary catheter
SPAT1167 [2001700268]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
0
7
464
4616
0
5
464
4618
—
—
—
—
—
Other leisure activity accident
Y94.8 [2000503731]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
0
8
464
4615
—
—
—
—
—
0
12
409
4134
Colonoscopy Study observation
28023-0 [3022145]
-6.9e-02
1.2e+00
—
—
—
9.3e-01
7.3e-01
cases:1.29%
controls:1.38%
cases:2.16%
controls:0.65%
—
—
—
—
—
—
cases:1.33%
controls:0.53%
cases:4.40%
controls:2.17%
6
64
458
4559
10
30
454
4593
—
—
—
6
24
444
4525
18
90
391
4056
esomeprazole; oral, parenteral
A02BC05 [21600100]
2.3e-01
6.2e-01
5.7e-01
—
1.5e-01
8.7e-02
1.2e-01
cases:9.27%
controls:7.51%
cases:7.33%
controls:4.09%
cases:1.29%
controls:0.74%
—
—
cases:1.08%
controls:0.93%
cases:4.44%
controls:4.09%
cases:8.56%
controls:7.67%
43
347
421
4276
34
189
430
4434
6
34
458
4589
—
5
43
458
4577
20
186
430
4363
35
318
374
3828
Other dental caries
K02.8 [45586690]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
0
14
464
4609
—
—
—
—
—
0
5
409
4141
insulin (beef); parenteral
A10AD02 [21600730]
-4.1e-01
-3.2e-01
7.4e-01
—
—
-3.0e-01
-5.5e-01
cases:1.72%
controls:2.57%
cases:1.94%
controls:2.66%
cases:1.08%
controls:0.52%
—
—
—
—
cases:2.00%
controls:2.68%
cases:1.96%
controls:3.35%
8
119
456
4504
9
123
455
4500
5
24
459
4599
—
—
9
122
441
4427
8
139
401
4007
trichlormethiazide; oral
C03AA06 [21601469]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.24%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
0
11
464
4612
0
8
464
4615
—
—
—
0
7
450
4542
—
Iron deficiency anaemia
D50 [45571628]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
0
5
464
4618
—
—
—
—
—
0
9
409
4137
Submitting image material and/or investigation material to patient
XX9CW [2001311045]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
464
4618
—
—
—
—
—
—
Pain general/multiple sites
A01 [2002000142]
7.0e-01
-1.0e+50
—
—
—
—
2.4e-01
cases:1.29%
controls:0.65%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
cases:1.71%
controls:1.35%
6
30
458
4593
0
8
464
4615
—
—
—
—
7
56
402
4090
Cells panel - Urine sediment
58434-2 [40761535]
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
0
5
463
4615
0
29
450
4520
—
clindamycin
D10AF01 [21602305]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
0
7
464
4616
—
—
—
—
—
doxepin; oral, parenteral
N06AA12 [21604699]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
0
27
464
4596
0
14
464
4609
—
—
—
—
—
Ocular pain
H57.1 [45596140]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
0
14
464
4609
—
—
—
—
—
—
Other oral or dental procedure
SXC05 [2001310586]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.43%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
0
20
464
4603
0
8
464
4615
—
—
—
—
—
Ultrasound examination of urinary bladder
SPAT1161 [2001700262]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
0
6
409
4140

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
78
264
3.32
18.72
10.3
8.8
16.93
15.70
%
3.58
78
256
126
564
2.66
18.25
8.1
7.4
1.51
0.91
mmol/l
0.96
110
479
125
566
2.62
17.62
8.3
7.4
7.41
7.41
ph
0.05
65
337
116
519
2.62
16.67
8.2
7.5
96.18
95.04
%
1.69
116
506
105
482
2.50
14.12
9.3
7.7
125.59
120.51
g/l
1.83
105
474
30
64
4.93
13.48
3.3
3.0
—
—
—
0
0
302
2145
2.05
13.21
14.3
14.3
1.22
1.25
inr
0.43
246
1774
116
581
2.30
12.73
1.4
1.3
—
—
—
0
0
274
1966
1.89
10.69
5.0
5.2
35.64
35.49
g/l
0.17
255
1852
214
1446
1.85
9.85
5.3
6.0
—
—
—
0
0
236
1669
1.79
9.16
2.5
2.2
—
—
—
0
0
330
2588
1.83
8.93
6.8
5.1
6.76
6.79
mmol/l
0.08
319
2470
292
2218
1.78
8.70
6.0
6.2
1.77
1.89
e9/l
1.07
244
1951
314
2440
1.79
8.61
8.4
10.0
4.46
4.15
e9/l
1.51
256
2126
289
2194
1.77
8.58
6.0
6.1
0.04
0.04
e9/l
0.10
236
1872
288
2185
1.76
8.56
6.0
6.1
0.63
0.60
e9/l
1.24
233
1861
295
2260
1.76
8.41
6.0
6.4
0.18
0.20
e9/l
0.73
245
1962
208
1451
1.75
8.21
3.0
3.5
35.95
34.16
u/l
0.10
197
1374
267
2013
1.71
7.84
7.3
6.5
1.20
1.21
mmol/l
1.66
255
1852
79
408
2.11
7.81
9.1
8.4
—
—
—
0
0
269
2034
1.71
7.80
6.4
6.1
59.44
57.74
%
1.81
260
1936
268
2026
1.71
7.76
6.5
6.3
0.61
0.67
%
1.06
256
1896
271
2064
1.70
7.56
6.8
6.2
25.42
26.82
%
1.39
260
1958
29
93
3.25
7.53
8.4
6.4
10.97
11.09
mmol/l
0.07
29
86
29
93
3.25
7.53
8.4
6.4
105.10
105.06
mmol/l
0.02
29
86
263
1990
1.69
7.49
3.1
2.8
—
—
estimate
—
0
0
200
1408
1.71
7.46
2.6
2.4
—
—
—
0
0
266
2030
1.67
7.24
6.5
6.2
2.78
2.92
%
0.43
255
1900
24
71
3.50
7.06
2.1
2.6
—
—
—
0
0
265
2033
1.66
6.97
6.6
6.3
8.96
9.04
%
0.21
253
1908
49
220
2.36
6.77
7.3
4.5
1.85
1.56
%
1.20
49
209
385
3274
1.80
6.77
10.0
8.7
81.41
80.09
u/l
0.28
370
3098
285
2239
1.65
6.73
8.9
7.4
1.20
1.21
mmol/l
1.32
249
1934
45
197
2.41
6.58
7.8
4.8
0.93
0.89
%
0.29
45
185
181
1288
1.64
6.22
4.2
4.5
—
—
—
0
0
18
48
3.85
6.14
3.3
3.3
3.77
6.79
nmol/l
0.41
18
48
73
401
1.96
6.06
1.6
1.5
—
—
—
0
0
243
1895
1.56
5.48
13.9
12.1
0.00
0.00
e9/l
0.76
182
1555
67
380
1.88
5.05
4.2
4.7
0.06
0.14
%
0.64
18
109
23
82
2.89
5.05
2.4
3.8
2.36
2.44
mmol/l
0.05
16
54
181
1356
1.53
4.72
3.9
4.4
7.40
7.40
ph
0.05
130
970
55
299
1.94
4.70
9.1
6.6
25.41
24.59
mmol/l
1.13
55
287
69
406
1.81
4.63
4.2
4.5
0.95
0.89
%
0.05
20
135
66
384
1.83
4.59
4.0
4.4
0.58
0.53
%
0.10
19
120
67
392
1.82
4.58
4.6
4.8
0.00
0.16
%
1.07
18
99
68
405
1.79
4.39
1.4
1.4
—
—
—
0
0
285
2372
1.48
4.31
7.6
7.0
10.63
11.61
umol/l
1.45
275
2268
345
2989
1.51
4.23
5.0
4.4
—
0.13
—
0
8
80
506
1.69
4.18
4.5
4.5
46.99
29.13
ug/l
0.17
71
424
28
123
2.35
4.11
3.7
3.1
1.19
1.97
index
0.60
16
75
209
1649
1.46
4.09
4.8
4.2
151.27
110.28
e6/l
0.25
158
1196
80
509
1.68
4.09
2.5
3.0
6.62
8.03
umol/l
0.69
70
451
47
266
1.85
3.59
1.4
1.2
172.68
268.32
u/ml
0.60
42
247
188
1482
1.43
3.58
4.2
3.6
546.64
104.32
e6/l
0.44
148
1154
125
929
1.46
3.21
1.8
1.7
1.25
1.36
mg/l
0.17
100
749
93
653
1.52
3.15
2.6
2.7
22.50
22.43
%
0.01
87
616
12
35
3.49
3.12
1.5
1.3
—
—
—
0
0
22
99
2.28
3.11
2.6
3.3
—
—
—
0
0
137
1046
1.43
3.03
2.8
2.8
5.69
4.33
e6/l
0.76
126
960
17
69
2.52
2.99
2.5
2.7
4.34
4.51
e9/l
0.12
17
69
161
1268
1.40
2.98
4.2
3.4
0.49
0.48
e6/l
0.02
116
946
93
669
1.48
2.80
2.5
2.1
—
—
—
0
0
95
689
1.47
2.74
2.7
2.7
2.34
2.27
g/l
0.63
90
641
24
120
2.05
2.65
1.8
2.2
134.43
126.26
g/l
0.51
14
94
100
742
1.44
2.56
2.7
2.7
12.99
12.66
umol/l
0.16
95
695
117
894
1.40
2.54
3.1
3.1
543.73
538.86
mosm/kgh2o
0.08
103
781
113
861
1.41
2.49
4.9
4.2
111.43
374.68
ng/l
2.09
94
706
97
725
1.42
2.38
4.0
3.3
3.32
1.68
e6/l
0.56
43
374
20
98
2.08
2.35
2.4
2.7
57.80
58.48
%
0.07
20
98
8
23
3.52
2.28
3.0
4.3
59.88
154.87
nmol/l
—
8
23
173
1429
1.32
2.27
3.3
2.7
55.22
121.29
u/l
0.63
165
1336
7
18
3.93
2.26
1.1
1.0
—
—
—
0
0
120
939
1.37
2.25
5.3
5.0
—
—
—
0
0
19
94
2.06
2.19
1.9
1.9
2.44
3.69
iu/l
—
7
34
14
61
2.33
2.16
4.1
1.9
10.36
10.32
mmol/l
0.01
14
61
15
68
2.24
2.13
1.8
1.5
—
—
—
0
0
15
68
2.24
2.13
1.8
1.5
—
—
—
0
0
15
68
2.24
2.13
1.8
1.5
—
—
—
0
0
15
68
2.24
2.13
1.8
1.5
—
—
—
0
0
178
1488
1.31
2.12
3.5
3.2
1014.09
1432.50
ng/l
1.91
154
1274
10
37
2.74
2.08
3.6
3.5
8.58
8.00
mmol/l
—
10
37
422
3988
1.40
1.90
24.6
17.5
24.89
24.86
mg/l
0.01
383
3326
7
22
3.21
1.88
1.3
1.2
165.00
195.85
mmol/24h
—
7
22
9
36
2.53
1.74
3.7
3.4
15.86
16.28
%
—
9
36
27
164
1.68
1.72
1.6
1.2
—
—
—
0
0
8
31
2.61
1.66
3.4
2.7
0.75
0.94
index
—
8
31
204
1787
1.24
1.56
4.9
4.1
23.62
75.70
ng/l
1.06
153
1347
75
580
1.35
1.52
1.3
1.3
594.29
522.57
titre
0.16
21
140
152
1292
1.26
1.51
6.0
6.5
—
—
—
0
0
47
336
1.44
1.51
3.9
3.9
—
—
—
0
0
47
338
1.43
1.46
4.4
3.5
5.15
5.16
kpa
0.02
47
327
31
206
1.54
1.41
1.2
2.0
1.64
1.45
g/l
0.48
26
187
6
23
2.63
1.37
2.7
1.3
167.33
83.30
ng/l
—
6
23
6
23
2.63
1.37
1.3
2.0
335.50
242.24
mu/l
—
6
17
11
54
2.06
1.33
1.5
1.8
—
—
—
0
0
6
25
2.42
1.24
1.3
1.3
—
—
—
0
0
10
49
2.06
1.22
2.0
1.8
11.31
11.03
%
—
10
49
5
19
2.65
1.22
1.4
2.5
397.80
875.84
u/ml
—
5
19
108
908
1.24
1.17
3.0
3.1
2.45
2.46
mmol/l
0.08
98
820
17
269
0.62
1.14
1.3
1.3
—
—
—
0
0
7
31
2.28
1.10
1.0
1.2
—
—
—
0
0
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
8
41
1.97
1.09
3.0
2.4
—
—
—
0
0
8
41
1.97
1.09
2.0
1.4
23.01
32.96
ng/l
—
8
41
149
1305
1.20
1.09
4.2
3.2
—
—
—
0
0
67
541
1.28
1.03
1.5
1.3
—
—
—
0
0
7
134
0.52
1.00
4.3
11.7
—
—
—
0
0
19
124
1.55
0.98
2.7
2.2
9.54
13.02
mg/l
1.23
19
115
12
198
0.60
0.97
1.4
1.6
—
—
—
0
0
10
54
1.87
0.97
1.3
1.4
—
—
—
0
0
9
50
1.81
0.97
1.2
1.2
—
—
—
0
0
27
191
1.44
0.97
3.2
3.0
—
—
—
0
0
154
1367
1.18
0.96
2.5
2.2
290.78
266.94
u/l
0.09
147
1299
64
520
1.27
0.95
1.9
1.7
—
—
—
0
0
429
4151
1.26
0.94
27.7
20.8
139.49
139.73
mmol/l
1.05
424
4081
60
484
1.27
0.94
5.0
3.7
7.37
7.38
ph
1.45
32
281
32
235
1.39
0.94
1.2
1.2
29.46
146.04
u/ml
—
9
88
51
406
1.29
0.89
2.4
2.5
41.81
32.70
u/l
0.47
42
341
429
4158
1.24
0.88
27.8
21.0
3.98
3.99
mmol/l
0.74
423
4081
57
464
1.26
0.84
4.6
3.7
0.98
2.06
mmol/l
0.91
47
397
68
565
1.24
0.84
2.1
1.5
—
—
—
0
0
15
225
0.66
0.83
2.1
2.4
—
—
—
0
0
19
130
1.48
0.82
1.3
1.4
287.73
301.68
ug/g
0.12
11
78
202
1856
1.15
0.79
3.6
3.0
129.15
138.36
ug/l
0.28
194
1729
13
82
1.60
0.78
1.6
2.1
4.87
4.78
mmol/24h
0.04
13
73
168
1525
1.15
0.78
3.9
3.7
2.36
2.35
mmol/l
0.57
154
1375
53
435
1.24
0.75
2.2
2.7
73.19
69.10
e9/l
0.26
34
338
11
68
1.63
0.72
4.1
3.5
0.68
1.11
%
0.56
11
61
16
109
1.48
0.71
1.4
1.7
—
—
—
0
0
9
57
1.59
0.71
1.0
1.3
0.12
0.18
nmol/l
—
9
40
88
765
1.18
0.71
1.4
1.3
62.85
37.07
iu/ml
0.38
28
241
10
157
0.63
0.70
2.4
1.7
39.70
41.15
nmol/l
—
10
150
89
780
1.17
0.66
4.6
3.3
0.80
0.82
mmol/l
1.04
81
738
291
2766
1.13
0.64
5.8
4.8
23.09
1416.65
e6/l
0.63
11
48
5
29
1.73
0.64
1.0
1.9
34.80
38.21
%
—
5
29
238
2239
1.12
0.61
4.1
4.0
0.00
0.00
estimate
-0.00
62
472
33
410
0.79
0.61
7.2
4.3
7.38
7.36
ph
0.82
27
299
8
50
1.61
0.61
1.5
1.3
—
—
—
0
0
285
2714
1.12
0.59
3.9
3.5
53.36
54.59
u/l
0.06
271
2539
58
497
1.19
0.57
2.4
2.4
124.31
123.41
ug/g
0.01
44
405
8
55
1.46
0.56
8.1
5.7
362.13
342.43
umol/l
—
8
49
82
924
0.86
0.56
1.4
1.3
0.61
1.47
u/ml
2.18
25
258
300
2870
1.12
0.56
5.0
4.6
—
2.94
—
0
7
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
25
195
1.30
0.55
1.4
1.8
—
—
—
0
0
133
1218
1.13
0.54
4.0
3.4
0.00
0.07
estimate
0.60
51
387
22
170
1.31
0.52
1.5
3.6
92.21
91.72
mg/l
0.00
17
144
22
170
1.31
0.52
1.5
3.7
37.20
42.85
mg/l
0.17
17
146
238
2255
1.11
0.52
4.1
4.0
0.03
0.00
estimate
0.41
64
485
6
40
1.51
0.51
1.0
1.2
—
—
—
0
0
207
1948
1.11
0.51
2.1
2.2
100.24
94.85
pmol/l
0.86
113
1034
90
1000
0.88
0.51
4.3
4.2
1.02
1.02
kg/l
0.01
60
674
430
4212
1.16
0.50
15.1
12.9
26.67
26.36
u/l
0.13
422
4100
7
107
0.65
0.49
1.0
1.3
—
—
—
0
0
142
1316
1.11
0.47
1.7
1.7
18.67
20.33
nmol/l
0.80
123
1103
85
764
1.14
0.47
1.9
1.7
1111.08
1166.19
nmol/l
0.27
64
588
40
339
1.20
0.46
3.4
2.6
6.13
6.06
ph
0.20
28
232
23
183
1.27
0.45
1.4
1.5
0.45
0.31
mg/l
—
10
84
7
51
1.38
0.44
1.3
1.1
—
—
—
0
0
319
3088
1.09
0.41
4.5
4.2
14.91
14.88
pmol/l
0.08
291
2794
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
17
215
0.78
0.40
1.9
2.3
0.00
0.01
estimate
—
6
68
120
1114
1.10
0.39
2.5
2.2
2.89
2.98
mg/l
0.15
106
966
9
66
1.37
0.38
1.1
1.3
0.54
0.56
nmol/l
—
9
61
6
42
1.43
0.35
1.0
1.5
—
—
—
0
0
9
124
0.72
0.35
1.9
1.7
241.11
221.64
pmol/l
—
9
114
399
4060
0.91
0.33
6.2
6.2
2.64
2.64
mmol/l
0.00
374
3749
124
1164
1.09
0.32
2.9
2.9
341.08
353.90
umol/l
0.80
112
1031
13
101
1.29
0.32
1.1
1.2
—
—
—
0
0
237
2283
1.07
0.32
4.3
4.0
0.00
0.69
estimate
0.51
55
446
7
96
0.73
0.31
1.1
1.2
5.43
1347.96
e6/l
—
7
75
11
84
1.32
0.30
1.6
3.6
5.72
9.94
pmol/l
2.06
11
84
11
84
1.32
0.30
1.4
1.5
—
—
—
0
0
19
157
1.22
0.30
1.4
3.3
1.12
2.78
ratio
—
7
88
401
3944
1.09
0.29
5.6
5.5
6.04
6.05
mmol/l
0.05
366
3609
159
1516
1.07
0.28
3.7
3.5
28.34
52.56
mg/l
2.52
107
990
194
1864
1.07
0.27
2.9
2.5
77.23
77.43
nmol/l
0.03
176
1666
10
127
0.78
0.25
7.5
4.1
—
—
—
0
0
186
1789
1.06
0.25
1.9
2.0
1.47
1.35
mmol/l
0.95
140
1488
391
3969
0.93
0.25
5.3
5.4
1.41
1.44
mmol/l
0.85
364
3658
414
4085
1.08
0.24
20.9
15.7
—
—
—
0
0
377
3708
1.07
0.24
5.8
5.2
1.87
1.98
mu/l
0.81
351
3368
59
544
1.10
0.24
1.6
1.7
—
—
—
0
0
11
136
0.80
0.23
1.2
1.1
—
—
—
0
0
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
162
1557
1.06
0.23
3.6
3.4
7.46
7.70
mmol/l
0.29
135
1302
62
575
1.09
0.22
1.4
1.3
—
—
—
0
0
7
94
0.74
0.22
1.1
1.2
1.86
17.99
e6/l
—
7
72
133
1272
1.06
0.22
4.4
4.1
0.00
0.00
estimate
0.50
56
436
86
911
0.93
0.21
2.2
1.8
399.03
20577106.56
pmol/l
0.69
73
763
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
27.09
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
5.6
—
—
—
0
0
9
111
0.81
0.20
1.2
1.2
—
—
—
0
0
394
3987
0.94
0.19
5.4
5.5
4.51
4.55
mmol/l
0.23
370
3698
34
309
1.11
0.19
4.1
2.9
129.59
129.49
g/l
0.01
34
301
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
7
58
1.21
0.18
1.1
1.3
—
—
nmol/l
—
0
0
7
60
1.17
0.18
1.1
1.1
—
—
—
0
0
16
138
1.16
0.17
1.6
1.8
—
—
—
0
0
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
21
186
1.13
0.17
2.0
1.9
1031.71
516.66
ug/l
0.25
21
178
6
80
0.75
0.15
1.2
1.0
—
—
—
0
0
45
420
1.08
0.15
1.2
1.6
—
—
—
0
0
377
3811
0.95
0.14
4.5
4.6
1.32
1.30
mmol/l
0.26
347
3485
13
112
1.17
0.14
1.1
1.2
—
—
—
0
0
75
717
1.05
0.13
1.3
1.3
14.85
15.17
u/ml
0.02
23
281
17
152
1.12
0.12
2.5
3.4
218.42
248.68
mg/l
0.17
12
62
117
1135
1.04
0.12
1.4
1.4
—
—
—
0
0
14
157
0.89
0.11
2.5
1.7
27.21
20.79
s
0.68
14
146
384
3871
0.96
0.10
7.0
7.0
40.35
39.94
mmol/mol
0.35
357
3626
17
187
0.91
0.10
1.1
1.1
—
—
—
0
0
106
1030
1.04
0.10
3.7
3.9
—
0.42
—
0
12
36
340
1.06
0.09
1.4
2.4
—
—
—
0
0
158
1548
1.03
0.09
4.3
4.2
6.53
8.38
mg/mmol
0.36
104
975
157
1602
0.97
0.09
5.3
3.8
—
0.60
—
0
5
5
47
1.06
0.09
1.2
1.2
—
—
—
0
0
16
175
0.91
0.08
1.5
2.1
8.47
10.69
g/l
2.26
16
160
19
175
1.09
0.08
3.1
4.0
25.30
25.18
mmol/l
0.06
19
162
179
1760
1.03
0.08
5.1
5.7
2.03
3.17
ug/l
1.64
163
1582
8
77
1.04
0.07
1.1
1.2
—
—
—
0
0
18
194
0.93
0.07
1.7
1.3
—
—
—
0
0
21
196
1.07
0.07
1.3
1.3
—
—
—
0
0
40
384
1.05
0.06
2.4
2.7
7.64
8.19
ug/l
0.09
35
341
9
101
0.89
0.06
1.6
1.4
—
—
—
0
0
432
4303
1.03
0.05
34.9
26.5
4.49
4.47
e12/l
0.30
424
4215
432
4303
1.03
0.05
34.9
26.6
7.14
6.75
e9/l
2.14
424
4214
432
4303
1.03
0.05
35.0
26.5
250.42
244.60
e9/l
1.07
425
4229
26
271
0.96
0.04
1.2
1.4
—
—
—
0
0
108
1066
1.02
0.03
2.9
3.3
0.60
0.78
ug/l
2.75
76
705
178
1795
0.99
0.03
3.6
3.6
6.22
6.19
ph
0.14
102
1025
27
261
1.04
0.02
1.2
1.5
—
—
—
0
0
83
841
0.98
0.02
1.5
1.3
2.34
2.65
g/l
1.13
63
496
155
1539
1.01
0.02
3.6
3.4
—
—
—
0
0
24
232
1.04
0.02
4.6
3.6
—
—
—
0
0
10
107
0.93
0.02
1.0
1.1
1.45
1.54
g/l
—
10
107
12
113
1.06
0.02
1.1
1.2
0.89
0.90
g/l
0.04
12
113
172
1710
1.01
0.01
4.3
3.9
0.00
0.04
estimate
1.71
52
397
19
183
1.04
0.01
1.8
1.7
1.68
8.50
iu/ml
—
5
48
14
134
1.05
0.00
3.4
3.1
1.79
1.61
mmol/l
0.59
14
128
15
156
0.96
0.00
1.5
1.5
8.04
11.88
u/ml
—
5
27
31
315
0.98
0.00
1.1
1.2
—
—
—
0
0
26
264
0.98
0.00
2.2
1.7
3.73
3.50
mmol/l
0.42
18
202
40
404
0.99
0.00
1.6
2.1
0.14
0.04
estimate
—
7
83
11
108
1.02
0.00
3.8
3.2
8.05
7.60
mmol/l
0.22
11
103
49
486
1.01
0.00
1.3
1.6
—
—
—
0
0
10
99
1.01
0.00
1.4
1.7
—
—
—
0
0
8
83
0.96
-0.00
1.1
1.3
—
—
—
0
0
8
85
0.94
-0.00
1.1
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
7.33
—
0
6
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
8
85
0.94
-0.00
1.1
1.3
—
—
—
0
0
8
79
1.01
-0.00
1.1
1.4
—
—
—
0
0
7
70
1.00
-0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
9
97
0.93
-0.00
1.3
1.4
1.02
0.86
nmol/l
—
9
82
0
7
0.00
-0.00
0.0
1.0
—
17.76
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
40.00
—
0
6
8
86
0.93
-0.00
1.1
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
0.02
—
0
8
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
8.10
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BRONCHUS_LUNG and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_BRONCHUS_LUNG 1.748 [1.41, 2.17] < 0.001
Birth year 0.993 [0.98, 1.0] 0.142

During the follow-up period (1.1.1998 — 31.12.2019), 137 out of 715 females with CD2_BENIGN_BRONCHUS_LUNG died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_BRONCHUS_LUNG 1.92 [1.6, 2.3] < 0.001
Birth year 0.992 [0.98, 1.0] 0.072

During the follow-up period (1.1.1998 — 31.12.2019), 241 out of 829 males with CD2_BENIGN_BRONCHUS_LUNG died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BRONCHUS_LUNG.

N-year risk Females Males
1 0.114% 0.359%
5 0.91% 2.593%
10 2.427% 6.229%
15 4.365% 11.649%
20 8.005% 19.781%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BRONCHUS_LUNG – Benign neoplasm: Bronchus and lung

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data